Other or unspecified ileus, impaction or obstruction

K11_OTHILEUS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K56.4, K56.6, K56.7 Hospital discharge: ICD-9 — 5608\|5609 Hospital discharge: ICD-8 — 5609 Hospital discharge: excluded ICD-9 — 5608A Cause of death: ICD-10 — K56.4, K56.6, K56.7 Cause of death: ICD-9 — 5608\|5609 Cause of death: ICD-8 — 5609 Cause of death: excluded ICD-9 — 5608A 2 out of 7 registries used, show all original rules.	10309
4. Check minimum number of events None	10309
5. Include endpoints None	10309
6. Filter based on genotype QC (FinnGen only)	9201

Control definitions (FinnGen only)

Control exclude: K11_INTESTOTH

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	K11_OTHILEUS
CONTROL_EXCLUDE	K11_INTESTOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K564\|K56[6-7]
HD_ICD_9	5608\|5609
HD_ICD_8	5609
HD_ICD_10_EXCL
HD_ICD_9_EXCL	5608A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K564\|K56[6-7]
COD_ICD_9	5608\|5609
COD_ICD_8	5609
COD_ICD_10_EXCL
COD_ICD_9_EXCL	5608A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other or unspecified ileus, impaction or obstruction based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	77370	39030	37319
Only index persons	56491	28754	27737
Unadjusted period prevalence (%)
Whole population	1.08	1.12	1.04
Only index persons	1.06	1.06	1.06
Median age at first event (years)
Whole population	68.71	70.35	66.98
Only index persons	66.98	68.35	65.57

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9201	4231	4970
Unadjusted period prevalence (%)	1.92	1.50	2.28
Median age at first event (years)	65.61	63.38	67.51

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9494: Matched controls
94895

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

6.7

323.3

528

825

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.5

318.2

828

1971

UJG02

NOMESCO Finland

Proctoscopy

9.4

317.7

384

422

K51.5

ICD-10 Finland

Left sided colitis

7.6

315.4

455

621

JF1BD

NOMESCO Finland

Very extensive small bowel CT

32.0

310.9

201

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

783.2

310.1

304

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

39.3

309.6

189

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.1

307.7

1212

2664

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

77.7

307.7

235

JFF23

NOMESCO Finland

Transversostomy

15.4

307.7

383

258

K50.9

ICD-10 Finland

Crohn disease, unspecified

22.5

307.7

430

200

130

Kela drug reimbursment

Malignant tumour

3.9

307.7

1807

5333

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

26.8

307.7

657

263

TJF80

NOMESCO Finland

Ostomy education

15.6

307.7

386

257

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

21.3

307.7

384

187

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

7.3

307.7

537

771

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

307.7

2904

12741

A07EC02

ATC

mesalazine; oral, rectal

6.1

307.7

823

1447

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

143.5

307.7

1680

142

A03FA01

ATC

metoclopramide; systemic, rectal

3.3

307.7

3165

12433

JN3AD

NOMESCO Finland

Abdominal CT examination

11.2

307.7

3699

5132

UJF30

NOMESCO Finland

Ileoscopy through colon

5.2

307.7

1167

2486

WX408

NOMESCO Finland

General anesthesy, balanced

2.8

307.7

3115

14183

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

7.6

307.7

1018

1472

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

9.1

307.7

1723

2260

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.8

307.7

2056

8566

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

41.0

307.7

244

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

40.1

307.7

204

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

8.5

307.7

864

1099

B01AB05

ATC

enoxaparin; parenteral

2.5

307.7

3825

20150

JN3BD

NOMESCO Finland

Extensive abdominal CT

10.4

307.7

2623

3346

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

307.7

2381

10632

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

63.8

307.7

715

121

JN4AD

NOMESCO Finland

Body CT examination

3.4

307.7

1886

6454

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

14.1

307.7

393

289

K56.7

ICD-10 Finland

Ileus, unspecified

3041.8

307.7

3083

JAH01

NOMESCO Finland

Laparoscopy

8.1

307.7

939

1272

TPH07

NOMESCO Finland

Cathetrisation of artery

3.7

307.7

1938

6134

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

35.5

307.7

283

A07EA06

ATC

budesonide; oral, local oral

7.4

307.7

612

873

K56.0

ICD-10 Finland

Paralytic ileus

2264.1

307.7

665

K56.2

ICD-10 Finland

Volvulus

3759.9

307.7

372

WX302

NOMESCO Finland

Thoracal epidural anesthesy

10.6

307.7

1743

1968

Z93.2

ICD-10 Finland

Ileostomy status

43.0

307.7

202

WX402

NOMESCO Finland

General anaesthesia

2.6

307.7

2548

11560

Z93.3

ICD-10 Finland

Colostomy status

18.3

307.7

299

168

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

5.5

307.7

5254

17500

L04AX01

ATC

azathioprine; systemic

5.8

307.7

694

1283

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.4

307.7

3755

15332

P01AB01

ATC

metronidazole; oral, rectal

2.6

307.7

3939

20407

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.2

307.7

2192

8188

JFA70

NOMESCO Finland

Suture of small intestine

53.5

307.7

194

R10.0

ICD-10 Finland

Acute abdomen

8.5

307.7

651

814

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

7.8

307.7

654

893

R11

ICD-10 Finland

Nausea and vomiting

4.3

307.7

1400

3672

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

15.3

307.7

1722

1356

N02AA05

ATC

oxycodone; systemic

2.8

307.7

2763

12133

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

5.6

307.7

1463

2986

UJF32

NOMESCO Finland

Coloscopy

6.9

307.7

4003

9117

K50.1

ICD-10 Finland

Crohn disease of large intestine

17.5

307.7

293

172

ZXD05

NOMESCO Finland

Urgent procedure

3.0

307.7

3873

17689

5609X

ICD-9 Finland

Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction

+∞

307.7

324

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

7.7

307.7

505

683

JFB00

NOMESCO Finland

Partial resection of small intestine

53.1

307.7

1081

229

K50.0

ICD-10 Finland

Crohn disease of small intestine

24.0

307.7

462

202

JFF10

NOMESCO Finland

Loop enterostomy

47.7

307.7

354

JAH00

NOMESCO Finland

Laparotomy

31.0

307.7

1541

590

A06AC01

ATC

ispaghula (psylla seeds); oral

2.7

307.7

2711

12093

JF1AD

NOMESCO Finland

Small bowel CT

37.9

307.7

273

JN4BD

NOMESCO Finland

Extensive body CT

3.3

307.7

1589

5463

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

14.1

307.7

1882

1631

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

10685.2

307.7

6575

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

13.0

307.7

351

280

K59.09

ICD-10 Finland

Constipation, unspecified

12.3

307.7

1295

1202

JFB30

NOMESCO Finland

Right hemicolectomy

13.2

307.7

481

381

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

63.6

307.7

266

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

10.9

307.7

468

449

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

68.3

307.7

253

K59.0

ICD-10 Finland

Constipation

8.1

307.7

933

1266

A06AD11

ATC

lactulose; oral

3.3

307.7

2309

8426

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

7397.2

307.7

1837

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

254.0

307.7

343

L01BC06

ATC

capecitabine; oral

6.8

307.7

997

1604

JFB20

NOMESCO Finland

Ileocaecal resection

31.1

307.7

222

JFB46

NOMESCO Finland

Resection of sigmoid colon

18.5

307.7

324

181

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

307.7

1799

6574

K50.8

ICD-10 Finland

Other Crohn disease

22.6

307.7

424

196

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

7.6

307.7

634

883

D01

ICPC

Abdominal pain/cramps general

3.3

304.0

1263

4160

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.5

301.5

611

1177

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.1

301.3

1411

4993

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

24.3

301.0

214

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

22.9

298.0

217

Z51.5

ICD-10 Finland

Palliative care

3.0

297.7

1520

5649

A04AA01

ATC

ondansetron; systemic, rectal

3.4

294.9

1200

3898

J01MA02

ATC

ciprofloxacin; systemic

2.2

294.0

4290

25884

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

19.4

292.9

229

121

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

290.6

5207

33995

B01AB10

ATC

tinzaparin; parenteral

3.0

287.1

1487

5563

ZXE20

NOMESCO Finland

More than three and less than five hours

2.8

286.6

1758

7201

K60.3

ICD-10 Finland

Anal fistula

132.8

285.8

144

56096

ICD-8 Finland

Intestinal obstruction without mention of hernia, Ileus propter adhaesionem (functione laesa circulationis intestinalis non indicata)

+∞

283.7

271

N02AX02

ATC

tramadol; systemic, rectal

2.2

283.2

4528

28192

A02BC02

ATC

pantoprazole; systemic

2.3

282.4

6815

49815

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.7

281.7

1877

8013

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

281.0

1573

6136

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.4

280.1

570

1101

JFF13

NOMESCO Finland

Terminal enterostomy

50.5

276.0

159

JFH10

NOMESCO Finland

Total colectomy and ileostomy

54.3

273.0

155

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

43.1

269.8

161

C10AC01

ATC

colestyramine; oral

6.8

268.7

432

663

A04AA02

ATC

granisetron; systemic, transdermal

3.5

262.2

983

3023

ZX120

NOMESCO Finland

Intravenous

3.1

260.3

1251

4473

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

15.5

259.1

226

149

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.7

257.5

1615

6663

H02AB02

ATC

dexamethasone; systemic

2.7

257.2

1573

6406

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.0

244.8

542

1126

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

1219.0

244.6

238

6453

FHL

Radical surgery of hemorrhoids

73.7

243.1

131

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.8

242.6

804

2274

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

59.5

241.9

135

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

11.3

239.1

252

228

K65.0

ICD-10 Finland

Acute peritonitis

10.3

236.4

267

JAL30

NOMESCO Finland

Omentectomy

9.5

233.4

280

304

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

232.1

3726

22757

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

231.4

2473

12929

JEA00

NOMESCO Finland

Appendectomy

3.8

228.8

760

2151

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

16.6

228.2

192

118

K61.0

ICD-10 Finland

Anal abscess

36.0

227.3

142

J01MA12

ATC

levofloxacin; systemic

2.3

224.6

2174

10893

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

6.7

223.9

361

555

A07EA02

ATC

hydrocortisone; rectal

7.5

222.3

325

449

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.2

219.6

605

1496

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.9

218.9

501

1069

128

Kela drug reimbursment

Cancers of female genital organs

6.5

210.9

349

551

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

23.6

210.2

151

K51.8

ICD-10 Finland

Other ulcerative colitis

9.2

208.4

255

284

JHA00

NOMESCO Finland

Anal or perianal incision

28.8

207.9

139

K59.1

ICD-10 Finland

Functional diarrhoea

4.4

206.8

536

1264

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

5.2

204.0

436

877

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

7.6

203.4

292

395

R50.9

ICD-10 Finland

Fever, unspecified

2.4

202.1

1695

7948

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.2

201.5

349

577

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.8

201.2

637

1741

N03AX16

ATC

[U] pregabalin

2.2

199.7

2299

12278

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

43.0

199.3

119

K59.01

ICD-10 Finland

Constipation outlet obstruction type

72.1

197.8

107

SPAT1125

SPAT

Stoma care and guidance

5.9

196.5

363

639

6561

FHL

Removal of fasteners and related measures

39.8

193.9

118

JKA20

NOMESCO Finland

Cholecystectomy

4.6

193.8

474

1067

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

7.6

193.6

279

379

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

193.2

3565

22495

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

190.0

963

3520

45599

ICD-8 Finland

Haemorrhoids

+∞

189.1

181

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

54.1

188.2

107

K92.1

ICD-10 Finland

Melaena

3.5

186.0

682

2055

JFC00

NOMESCO Finland

Entero-enterostomy

51.0

184.3

106

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.6

184.1

641

1867

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

183.7

1662

8023

C20

ICD-10 Finland

Malignant neoplasm of rectum

8.4

183.2

241

294

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.2

183.0

382

752

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

182.5

1064

4186

D99

ICPC

Disease digestive system other

9.6

179.6

212

225

JFB43

NOMESCO Finland

Left hemicolectomy

15.6

177.8

154

100

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

17.5

177.4

145

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

40.1

176.1

107

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

8.6

175.2

226

269

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

172.5

882

3233

D12

ICPC

Constipation

4.2

170.6

466

1142

D94

ICPC

Chronic enteritis/ulcerative colitis

14.7

169.7

152

105

R4190

NOMESCO Finland

Nutritional therapy

4.0

166.2

491

1275

JAD10

NOMESCO Finland

Repair of incisional hernia

11.3

165.9

174

156

Z93

ICD-10 Finland

Artificial opening status

20.7

165.3

125

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

164.8

1338

6143

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

5.9

164.3

298

515

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

47.9

163.0

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

8.8

162.3

204

235

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.7

162.1

546

1553

WW500

NOMESCO Finland

Blood transfusion

3.6

161.7

569

1666

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

801.6

161.0

158

B03BA03

ATC

hydroxocobalamin; parenteral

2.9

159.7

808

2941

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

4.9

158.2

358

755

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.4

158.1

597

1829

UJF92

NOMESCO Finland

Capsular endoscopy

6.9

157.9

246

364

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

62.7

157.1

N02BE01

ATC

paracetamol; systemic, rectal

2.3

156.9

8352

71964

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

5.5

156.2

305

565

D75

ICPC

Malignant neoplasm colon/rectum

8.7

155.4

198

232

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

6.5

155.3

256

402

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.6

155.0

383

868

K60.1

ICD-10 Finland

Chronic anal fissure

18.6

154.8

123

A02BC01

ATC

omeprazole; systemic

1.9

154.1

2671

16260

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

152.1

1609

8220

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

12.6

152.1

149

120

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

9.3

150.7

182

199

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

8.7

149.4

190

222

56099

ICD-8 Finland

Intestinal obstruction without mention of hernia, Other and unspecified

+∞

149.3

143

WZC30

NOMESCO Finland

Teaching

2.1

149.1

1750

9296

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

8.2

146.9

196

243

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.4

146.7

545

1651

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.9

142.7

720

2612

J01DB01

ATC

cefalexin; oral

1.9

141.5

7431

62031

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

141.0

2993

19300

C56

ICD-10 Finland

Malignant neoplasm of ovary

10.0

140.2

160

162

UJF02

NOMESCO Finland

Peroral enteroscopy

15.2

140.0

123

5608A

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]

+∞

139.9

134

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

16.0

139.5

119

JFB50

NOMESCO Finland

Other resection of colon

22.7

138.5

101

K50

ICD-10 Finland

Crohn disease [regional enteritis]

29.6

137.4

N05CF01

ATC

zopiclone; oral

1.8

137.3

3205

21217

K62.3

ICD-10 Finland

Rectal prolapse

25.9

137.1

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

5.9

136.8

248

428

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

136.7

614

2086

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

17.0

136.6

113

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

5.8

136.4

252

443

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

4.7

136.4

320

695

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.9

136.2

419

1118

JF2AB

NOMESCO Finland

Colongraphy with X-ray

22.7

135.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

134.9

3391

22899

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

134.4

1653

8899

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

5.1

133.6

285

571

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

9.4

133.6

160

173

UJH02

NOMESCO Finland

Anoscopy

4.7

131.7

315

695

56095

ICD-8 Finland

Intestinal obstruction without mention of hernia, Ileus propter adhaesionem, cum functione laesa circulationis intestinalis

+∞

131.5

126

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

9.6

130.7

154

163

A02BC05

ATC

esomeprazole; systemic

1.7

130.3

3560

24543

K56.4

ICD-10 Finland

Other impaction of intestine

436.8

130.2

130

Z43.2

ICD-10 Finland

Attention to ileostomy

29.9

130.2

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

9.1

129.9

159

177

WF001

NOMESCO Finland

Preoperative radiotherapy

7.1

129.1

196

282

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.3

128.3

344

830

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

30.2

127.7

JFC20

NOMESCO Finland

Other enterocolostomy

55.8

127.2

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

6.8

125.5

199

300

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

125.3

1784

10083

SPAT1262

SPAT

Handing over of treatment supplies

1.9

125.0

1852

10607

K66.0

ICD-10 Finland

Peritoneal adhesions

16.2

125.0

106

A41.9

ICD-10 Finland

Sepsis, unspecified

3.2

124.2

510

1642

WX882

NOMESCO Finland

High dependency care

3.9

123.5

381

1018

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

13.7

122.7

114

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

10.2

121.8

137

136

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

6.7

121.7

193

291

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

119.8

1172

5768

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.6

119.2

413

1194

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

5.2

117.8

245

480

L01BB02

ATC

mercaptopurine; oral

8.1

116.9

158

199

L01BC59

ATC

trifluridine, combinations; systemic

13.0

116.8

112

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

116.6

375

1031

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.2

116.5

484

1568

WX892

NOMESCO Finland

Monitored bed care

2.4

116.0

865

3796

UKC02

NOMESCO Finland

Cystoscopy

1.9

115.6

1723

9860

H02AB06

ATC

prednisolone; systemic

1.6

115.1

4391

32698

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.6

115.0

388

1102

6402

FHL

Small bowel resection

25.7

113.6

C03CA01

ATC

furosemide; systemic

1.7

112.8

3486

24583

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.7

112.5

268

589

TKC20

NOMESCO Finland

Catheterisation of bladder

2.4

112.5

833

3642

E86

ICD-10 Finland

Volume depletion

3.6

111.7

386

1114

WX704

NOMESCO Finland

Intubation

2.4

111.1

851

3776

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

13.7

110.7

103

R18

ICD-10 Finland

Ascites

4.2

110.4

305

752

ZXE00

NOMESCO Finland

One hour or less

1.7

110.4

3415

24052

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.8

110.0

573

2109

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

6.9

109.3

169

248

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.9

109.1

335

892

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

13.5

109.0

102

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.9

108.9

523

1841

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

108.7

1626

9299

JFC10

NOMESCO Finland

Ileotransversostomy

37.5

108.3

WX002

NOMESCO Finland

Sedation and analgesia

1.8

108.2

1808

10708

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

14.6

108.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

107.4

778

3365

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.5

107.1

208

383

A02BC03

ATC

lansoprazole; oral

1.7

106.6

2572

16941

A28

ICPC

Limited function/disability NOS

1.8

105.6

2058

12757

JHD00

NOMESCO Finland

Anal dilatation

23.2

105.2

R53

ICD-10 Finland

Malaise and fatigue

1.7

105.1

2297

14711

WVA20

NOMESCO Finland

Medicine administration

3.6

104.6

351

993

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.8

104.3

561

2099

N06AX11

ATC

mirtazapine; oral

1.7

103.1

2949

20278

JAL00

NOMESCO Finland

Biopsy of peritoneum

9.7

103.0

120

125

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

11.5

102.4

106

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

9.6

102.4

120

126

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.4

102.4

203

381

L04AC05

ATC

ustekinumab; parenteral

13.0

102.3

A07DA03

ATC

loperamide; oral

3.2

101.7

411

1309

JAH33

NOMESCO Finland

Opening of laparostomy

37.3

101.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

101.5

1408

7837

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

101.3

509

1836

R33

ICD-10 Finland

Retention of urine

2.2

101.3

977

4766

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

40.9

100.7

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

7.5

100.5

145

197

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

100.4

810

3671

S18

ICPC

Laceration/cut

1.6

100.0

4313

32695

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

18.5

99.4

B81

ICPC

Anaemia vit B12/folate deficiency

2.9

99.3

486

1728

SPAT1255

SPAT

Intravenous administration of medicine

2.4

98.2

729

3184

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

24.8

97.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

97.8

1590

9306

E87.6

ICD-10 Finland

Hypokalaemia

3.1

97.7

431

1445

N05AH02

ATC

clozapine; systemic

5.4

97.3

194

366

K56.1

ICD-10 Finland

Intussusception

+∞

97.0

XX9TB

NOMESCO Finland

Complementary X-ray examination with contrast

20.1

96.6

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.7

96.5

317

884

D06

ICPC

Abdominal pain localized other

2.4

96.4

700

3027

N05BA04

ATC

oxazepam; oral

1.7

95.6

2327

15285

SPAT1254

SPAT

Administration of medicine

1.9

95.5

1487

8580

LCD00

NOMESCO Finland

Hysterectomy

3.0

95.5

449

1561

Z2446

NOMESCO Finland

Social worker

2.5

95.4

613

2504

UJF34

NOMESCO Finland

Left colonoscopy

10.6

95.2

104

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

6.6

94.7

152

232

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

94.4

663

2823

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

94.3

709

3114

WX610

NOMESCO Finland

Patient controlled analgesia

8.8

93.4

117

134

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.2

93.4

385

1240

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

5.0

92.6

200

405

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.5

91.9

150

233

D18

ICPC

Change in faeces/bowel movements

3.8

91.8

281

746

K63.9

ICD-10 Finland

Disease of intestine, unspecified

18.4

91.5

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.5

91.4

179

332

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

19.3

91.0

WGA11

NOMESCO Finland

Planning of pain management

9.8

90.9

105

108

WX600

NOMESCO Finland

Single shot through catheter

5.0

90.1

197

403

A06AH03

ATC

naloxegol; oral

4.8

90.0

207

442

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.1

89.6

382

1255

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

41.8

89.6

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

9.0

89.5

110

123

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

26.0

89.5

N30.0

ICD-10 Finland

Acute cystitis

1.8

89.0

1503

8878

JFF26

NOMESCO Finland

Sigmoidostomy

26.7

88.8

UJD02

NOMESCO Finland

Gastroscopy

2.8

88.7

479

1793

JF2BD

NOMESCO Finland

Extensive colon CT

10.0

88.6

101

102

256, ,

Kela drug reimbursment

23.0

88.3

R4110

NOMESCO Finland

Physiotherapy

1.6

87.6

2499

17035

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.3

87.4

232

555

K92.0

ICD-10 Finland

Haematemesis

3.4

87.3

316

939

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

18.1

87.0

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

18.1

87.0

A03FA02

ATC

cisapride; oral, rectal

2.3

86.6

730

3363

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

11.2

86.4

6101

FHL

Exploratory laparotomy, includes possible biopases

10.7

86.3

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.0

85.7

249

637

JGC01

NOMESCO Finland

Laparoscopic rectopexy

25.1

85.6

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

4.2

85.4

232

565

SPAT1263

SPAT

Sampling

1.6

85.3

3531

26223

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.8

85.3

440

1608

N05AA02

ATC

levomepromazine; systemic

2.9

85.3

418

1486

N03AX12

ATC

[U] gabapentin; oral

1.8

84.7

1352

7838

K62.1

ICD-10 Finland

Rectal polyp

18.0

84.4

A02BA02

ATC

ranitidine; systemic

1.7

83.8

1761

11064

D11

ICPC

Diarrhoea

2.1

83.5

879

4420

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

83.4

5914

49195

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

19.2

83.2

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

83.2

320

988

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.1

82.8

361

1201

Z3231

NOMESCO Finland

Registered nurse

1.6

82.8

2472

16999

N06AX21

ATC

duloxetine; oral

2.0

82.7

927

4771

253, ,

Kela drug reimbursment

18.7

82.1

D10

ICPC

Vomiting

2.8

81.9

427

1569

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

81.8

1134

6280

J01EA01

ATC

trimethoprim; systemic

1.6

81.7

2236

15043

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

81.3

411

1485

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

81.1

444

1673

3042, ,

Kela drug reimbursment

18.2

81.0

K31.5

ICD-10 Finland

Obstruction of duodenum

20.1

80.9

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

41.0

80.9

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

80.8

568

2417

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

21.5

80.6

107

Kela drug reimbursment

Pernicious anaemia

3.5

80.4

281

816

Z43.3

ICD-10 Finland

Attention to colostomy

16.3

80.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

80.1

862

4367

UJK02

NOMESCO Finland

ERCP

3.1

80.1

342

1124

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

80.1

298

901

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

47.2

80.1

N06AB04

ATC

citalopram; systemic

1.7

79.1

1748

11113

AA1AD

NOMESCO Finland

CT of head and brain

1.6

78.9

2800

20004

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

6.8

78.5

122

180

JFB40

NOMESCO Finland

Resection of transverse colon

18.1

78.4

6419

FHL

Other measure in this category

33.5

78.2

N05AH04

ATC

quetiapine; oral

1.8

77.9

1411

8482

L04AB04

ATC

adalimumab; parenteral

4.1

77.8

214

526

R15

ICD-10 Finland

Faecal incontinence

3.7

77.6

255

711

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.6

76.8

257

725

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

76.2

906

4756

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

8.4

75.7

117

JFH11

NOMESCO Finland

Laparoscopic colectomy

34.4

75.6

K57.0

ICD-10 Finland

Diverticular disease of small intestine with perforation and abscess

744.0

75.3

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

9.6

75.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

75.3

4172

32687

K62.0

ICD-10 Finland

Anal polyp

29.5

75.3

K63.2

ICD-10 Finland

Fistula of intestine

+∞

75.1

N05BA01

ATC

diazepam; systemic, rectal

1.8

75.0

1162

6658

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

4.9

74.6

164

337

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

74.5

592

2656

JFF30

NOMESCO Finland

Other colostomy

27.0

74.5

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

8.1

74.4

100

125

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.2

74.2

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

13.0

74.1

1470

FHL

Rectoscopy

14.3

74.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

74.0

3254

24285

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.5

73.8

254

730

K62.2

ICD-10 Finland

Anal prolapse

24.9

73.8

K63.5

ICD-10 Finland

Polyp of colon

7.7

73.7

103

135

JG1BG

NOMESCO Finland

MRI of rectum

6.4

73.4

121

190

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.4

73.2

183

418

369

Kela drug reimbursment

Regorafenib

11.4

73.2

R06.0

ICD-10 Finland

Dyspnoea

1.6

72.8

2401

16813

N06AA09

ATC

amitriptyline; systemic

2.0

72.4

834

4325

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

72.4

662

3147

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

72.1

345

1210

5608X

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS, MUU SYY]

+∞

71.9

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

24.4

71.9

E0000UV, ,

ATC

1.5

71.8

3446

26149

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.1

71.7

316

1058

A04AA55

ATC

palonosetron, combinations; systemic

2.9

71.7

352

1252

D28

ICPC

Limited function/disability (D)

11.3

71.6

JDE00

NOMESCO Finland

Gastrojejunostomy

11.3

71.6

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

71.4

658

3138

N05AH03

ATC

olanzapine; systemic

2.4

71.3

530

2309

K83.0

ICD-10 Finland

Cholangitis

4.1

71.3

201

503

B01AB04

ATC

dalteparin; parenteral

2.4

70.9

536

2353

JG1CG

NOMESCO Finland

Extensive MRI of rectum

6.8

70.5

110

163

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

10.8

70.4

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

8.6

70.3

106

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

6.6

69.8

113

174

N05CD07

ATC

temazepam; oral

1.8

69.5

1196

7064

K57

ICD-10 Finland

Diverticular disease of intestine

5.7

69.4

129

228

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

22.3

69.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

69.4

618

2906

A06AC51

ATC

ispaghula, combinations; oral

2.8

69.3

366

1353

A07AA09

ATC

vancomycin; oral

4.4

69.1

176

408

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

69.1

958

5291

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

68.9

528

2331

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

68.6

261

800

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

5.1

68.3

143

282

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

67.6

620

2950

JFB01

NOMESCO Finland

Laparoscopic partial resection of small intestine

27.2

67.3

SPAT1153

SPAT

Removal of sutures

1.5

67.1

2759

20206

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

10.6

67.1

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

9.2

66.8

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

66.7

1479

9368

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

66.7

412

1648

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

66.6

1851

12413

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

66.6

516

2289

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

6.5

66.5

108

167

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

66.4

2958

22017

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.2

66.2

263

828

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

119.2

65.9

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.8

65.9

148

310

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

6.9

65.9

102

150

K83.1

ICD-10 Finland

Obstruction of bile duct

3.9

65.6

195

507

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

18.7

65.6

JFA80

NOMESCO Finland

Suture of colon

23.6

65.4

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

4.5

65.0

158

353

K65.9

ICD-10 Finland

Peritonitis, unspecified

12.4

64.9

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

24.3

64.7

56098

ICD-8 Finland

Intestinal obstruction without mention of hernia, Alii definiti

+∞

64.6

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

64.3

608

2925

SPAT1301

SPAT

No procedures

1.5

64.0

2741

20204

A06AX04

ATC

linaclotide; oral

21.0

63.7

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

21.0

63.7

C05AA08

ATC

fluocortolone; rectal, topical

1.8

63.5

1029

5961

Z3226

NOMESCO Finland

Physiotherapist

1.6

63.4

1535

9937

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

63.2

1007

5803

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

10.4

63.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

63.1

3570

27782

JFK01

NOMESCO Finland

Laparoscopic division of adhesive band in intestinal obstruction

99.3

62.9

JAK00

NOMESCO Finland

Laparotomy and drainage of peritoneal cavity

17.7

62.7

L28

ICPC

Limited function/disability (L)

1.6

62.2

1848

12567

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

62.0

281

956

L03AA02

ATC

filgrastim; parenteral

2.8

61.9

323

1186

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.9

61.9

182

470

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.1

61.6

257

833

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

12.0

61.6

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

8.2

61.4

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

15.7

61.4

A04

ICPC

Weakness/tiredness general

1.7

61.4

1341

8447

JG1JB

NOMESCO Finland

Defekography with X-ray

10.5

61.1

J01MA14

ATC

moxifloxacin; systemic

1.9

61.1

810

4400

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

8.2

60.6

H02AB07

ATC

prednisone; oral

1.7

60.6

1189

7274

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.6

60.3

204

580

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

9.5

60.3

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.0

60.3

272

923

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.6

60.1

358

1406

R51.80

ICD-10 Finland

Headache

1.8

59.7

1063

6323

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

18.9

59.6

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

5.5

59.5

115

211

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

59.4

1503

9822

N05AF03

ATC

chlorprothixene; systemic

3.2

59.2

242

775

D02

ICPC

Abdominal pain epigastric

2.3

59.2

490

2234

N02BF02

ATC

pregabalin; oral

2.2

59.1

554

2655

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.4

59.0

429

1850

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

12.4

58.9

J01DA01

ATC

[U] cefalexin

1.4

58.7

5122

42912

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

13.1

58.7

JAK03

NOMESCO Finland

Laparotomy and peritoneal irrigation

18.2

58.5

R52.2

ICD-10 Finland

Other chronic pain

2.7

58.5

318

1193

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

58.4

445

1958

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

298.9

58.3

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

15.1

57.9

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

10.4

57.8

K51

ICD-10 Finland

Ulcerative colitis

5.5

57.6

111

203

D17

ICPC

Incontinence of bowel

4.9

57.4

126

259

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.4

57.2

146

339

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

6.5

57.2

144

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.9

57.0

275

968

J02AC01

ATC

fluconazole; systemic

1.5

57.0

2693

20149

5604

FHL

Vascular preparation or cannulation in the operating room

17.8

56.7

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.2

56.7

472

2157

A41.8

ICD-10 Finland

Other specified sepsis

3.1

56.6

236

765

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

5.0

56.5

122

247

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

3.1

56.5

241

792

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

7.8

56.4

101

5621B

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULITIS COLI SINE HAEMORRHAGIA]

+∞

56.3

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

4.1

56.0

155

383

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

55.2

2071

14772

K59.3

ICD-10 Finland

Megacolon, not elsewhere classified

+∞

55.2

56500

ICD-8 Finland

Anal fissure and fistula, Anal fissure

+∞

55.2

D29

ICPC

Digestive symptom/complaint other

3.2

55.2

217

679

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

55.0

2330

17038

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

55.0

1528

10196

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

54.9

510

2435

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

20.1

54.7

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

18.8

54.3

G04CA02

ATC

tamsulosin; oral

1.5

54.2

2414

17819

N06AX16

ATC

venlafaxine; oral

1.8

54.2

940

5542

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

7.4

54.1

106

K62.4

ICD-10 Finland

Stenosis of anus and rectum

187.7

54.0

K62.6

ICD-10 Finland

Ulcer of anus and rectum

8.2

53.7

L03AA13

ATC

pegfilgrastim; parenteral

2.3

53.7

418

1856

TPX15

NOMESCO Finland

Removal of vascular injection port

7.3

53.6

107

M54.5

ICD-10 Finland

Low back pain

1.5

53.6

2717

20554

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.0

53.5

155

396

JMA10

NOMESCO Finland

Transabdominal total splenectomy

6.5

53.4

135

176

Kela drug reimbursment

Regorafenib

9.1

53.3

R03BB04

ATC

tiotropium bromide; inhalant

1.7

53.2

986

5923

L04AA33

ATC

[U] vedolizumab

21.1

53.2

B80

ICPC

Iron deficiency anaemia

3.0

53.1

232

773

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

4.4

53.0

132

301

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.3

53.0

406

1791

A01

ICPC

Pain general/multiple sites

1.8

52.9

835

4786

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

14.2

52.7

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

6.5

52.5

131

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.4

52.4

194

585

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

5.5

52.1

101

186

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

52.1

2131

15449

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.0

51.9

111

223

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

51.9

583

2987

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.1

51.8

141

344

WX730

NOMESCO Finland

Conventional respirator

3.4

51.7

191

575

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.4

51.7

192

580

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.1

51.4

223

740

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.1

51.3

212

684

H02AB09

ATC

hydrocortisone; systemic

3.1

51.2

214

695

4556A

ICD-9 Finland

Haemorrhoids, Unspecified haemorrhoids without mention of complication

+∞

51.1

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

13.4

51.0

S97

ICPC

Chronic ulcer skin

1.9

50.7

640

3415

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

11.6

50.6

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

50.6

306

1211

E87.5

ICD-10 Finland

Hyperkalaemia

3.0

50.6

230

784

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

50.5

1527

10370

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

4.5

50.4

123

276

K59.8

ICD-10 Finland

Other specified functional intestinal disorders

12.2

50.4

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.5

50.2

175

508

5621A

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULOSIS COLI]

+∞

50.0

JJB10

NOMESCO Finland

Atypcal resection of liver

9.6

49.4

K61.1

ICD-10 Finland

Rectal abscess

490.3

49.4

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

5.9

49.4

153

L04AG05

ATC

vedolizumab; parenteral

14.7

49.3

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.8

49.2

256

939

A04AD12

ATC

aprepitant; systemic

3.1

49.1

203

655

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

3.0

49.1

217

728

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

49.0

1461

9883

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

49.0

820

4779

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.1

48.9

202

651

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

6.4

48.8

125

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

48.8

1201

7766

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

10.0

48.6

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

48.6

632

3405

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

48.3

222

761

WX872

NOMESCO Finland

Intensive care

2.1

48.3

501

2493

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.7

48.3

157

435

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

48.0

649

3541

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022948) Iron [Moles/volume] in Serum or Plasma

2773

13528

2.48

319.40

3.3

2.5

10.97

12.76

umol/l

28.07

2626

12493

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2363

10710

2.60

317.98

7.3

5.5

1.03

1.04

mmol/l

0.93

2247

9892

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3549

18249

2.51

307.65

4.0

2.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1134

2805

4.45

307.65

5.1

3.5

1094.12

2301.54

u/ml

0.55

996

2424

(3024561) Albumin [Mass/volume] in Serum or Plasma

6069

36071

2.89

307.65

10.7

4.6

32.84

35.09

g/l

139.73

5823

33468

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1971

6488

3.57

307.65

4.0

2.3

38.54

61.31

u/l

1.02

1749

5435

(3013650) Neutrophils [#/volume] in Blood by Automated count

6496

42854

2.63

307.65

18.2

9.1

4.58

4.27

e9/l

15.06

5857

36592

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2279

9839

2.73

307.65

9.5

7.1

5.10

5.09

kpa

0.25

2204

9420

(3019977) pH of Arterial blood

2298

9811

2.77

307.65

9.6

7.2

7.41

7.42

1.53

1248

5488

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3020

13471

2.82

307.65

5.6

3.2

0.80

0.82

mmol/l

14.07

2883

12566

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2697

8112

4.24

307.65

6.8

4.2

16.62

30.81

ug/l

2.14

2311

6758

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5808

35006

2.70

307.65

4.4

2.7

—

estimate

—

(3003396) Base excess in Arterial blood by calculation

2276

9755

2.75

307.65

9.5

7.1

1.06

1.02

mmol/l

0.18

1942

7985

(3042936) Bacteria identified in Isolate by Culture

2563

11050

2.81

307.65

2.7

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2087

8417

2.89

307.65

5.4

3.7

5.79

5.81

kpa

0.56

2037

8208

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7020

40167

3.87

307.65

12.5

6.4

11.32

12.40

umol/l

9.53

6873

38123

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3790

20395

2.43

307.65

3.3

2.2

3.09

2.88

mg/l

5.41

3390

17395

(3032080) INR in Blood by Coagulation assay

6274

38781

2.82

307.65

18.2

16.8

1.25

1.32

inr

25.18

5513

32447

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

910

2258

4.35

307.65

1.5

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2280

9834

2.73

307.65

9.5

7.1

12.80

12.08

kpa

7.64

2204

9405

(3048689) Calprotectin [Mass/mass] in Stool

1778

6224

3.28

307.65

4.3

2.1

246.66

134.65

ug/g

17.21

1530

4908

(3013826) Glucose [Moles/volume] in Serum or Plasma

6735

46599

2.53

307.65

8.8

4.8

6.83

6.85

mmol/l

0.43

6568

44266

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2091

7344

3.37

307.65

3.1

2.1

0.20

g/l

2.15

1965

6782

(3023368) Bacteria identified in Blood by Culture

4854

23345

3.21

307.65

6.8

4.2

—

(3002032) Base excess in Venous blood by calculation

2053

8154

2.94

307.65

5.4

3.7

2.13

1.84

mmol/l

2.22

1797

7075

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2006

7989

2.91

307.65

10.1

8.0

117.08

121.51

g/l

17.52

1966

7788

(3022145) Colonoscopy Study observation

1952

5674

4.07

307.65

1.8

1.3

—

(3012544) pH of Venous blood

2116

8508

2.91

307.65

5.4

3.7

7.38

0.62

1285

5035

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2032

5002

4.89

307.65

2.1

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5320

22582

4.08

307.65

4.4

2.5

62.28

64.12

u/l

0.15

5149

20714

(3016502) Oxygen saturation in Arterial blood

2127

8672

2.87

307.65

9.7

7.4

95.90

95.32

4.15

2063

8343

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2111

8232

3.01

307.65

4.2

2.7

9.29

9.97

umol/l

0.55

1880

7221

(3014111) Lactate [Moles/volume] in Serum or Plasma

2065

7228

3.37

307.65

8.3

7.2

1.36

1.39

mmol/l

0.37

2030

7055

(3044640) Blood type and Crossmatch panel - Blood

4626

24312

2.76

307.65

4.1

2.4

—

(3000991) Gas panel - Venous blood

1832

6989

3.01

307.65

10.7

8.4

—

(3026008) Bacteria identified in Urine by Culture

4168

24750

2.22

298.62

4.8

3.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2597

12664

2.44

296.07

3.2

2.4

2.27

2.26

g/l

0.32

2430

11628

(3020779) Urea [Moles/volume] in Serum or Plasma

1824

7531

2.76

293.43

8.4

6.6

10.12

10.65

mmol/l

2.07

1755

7144

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5992

41313

2.22

291.37

11.6

6.8

1.20

1.21

mmol/l

56.35

5250

35189

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7718

59279

2.61

290.39

17.0

7.7

88.60

81.47

u/l

17.15

7537

55810

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2443

11733

2.46

286.78

3.3

2.5

19.52

22.60

24.50

2314

10812

(3024354) Oxygen [Partial pressure] in Venous blood

1718

7011

2.77

281.75

4.6

3.1

4.61

4.44

kpa

2.00

1674

6820

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5490

36886

2.16

280.72

10.8

6.2

1.19

1.21

mmol/l

59.32

5182

33872

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1415

5219

3.01

279.82

9.4

7.8

24.87

24.77

mmol/l

0.41

1404

5172

(3002582) Erythrocytes [#/volume] in Urine

4286

26417

2.13

271.82

4.8

3.3

79.16

94.42

e6/l

0.40

3531

20042

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2748

14190

2.32

271.31

2.4

1.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4000

24030

2.15

271.05

5.2

3.2

37.23

35.30

u/l

0.32

3797

22554

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1289

4624

3.07

267.01

5.7

3.9

24.28

24.20

mmol/l

0.30

1277

4561

(3000850) Epithelial cells [#/volume] in Urine

3256

18147

2.21

266.11

3.7

2.7

5.62

5.32

e6/l

0.55

3032

16468

(3031040) Bacteria [#/volume] in Urine by Automated count

6787

50500

2.20

254.12

7.4

4.5

2057.87

1903.52

e6/l

0.08

142

813

(3014007) Fractional oxyhemoglobin in Arterial blood

1385

5349

2.86

250.14

11.1

9.2

94.25

93.75

2.38

1378

5326

(3030467) Casts [#/volume] in Urine by Automated count

3780

22775

2.09

248.56

4.6

3.2

0.62

0.48

e6/l

1.88

3044

16671

(3001604) Monocytes [#/volume] in Blood

5522

38260

2.06

246.54

9.4

5.8

0.62

0.61

e9/l

1.74

4859

32199

(3006315) Basophils [#/volume] in Blood

5537

38402

2.06

246.53

9.4

5.8

0.04

e9/l

1.08

4867

32355

(3013115) Eosinophils [#/volume] in Blood

5648

39474

2.06

245.95

9.8

6.0

0.18

0.20

e9/l

10.84

5006

33878

(3026782) Osmolality of Urine

2871

15632

2.20

244.99

4.0

2.9

517.65

538.60

mosm/kgh2o

5.72

2605

13663

(3019198) Lymphocytes [#/volume] in Blood

5589

39174

2.04

238.13

9.5

5.9

1.72

1.90

e9/l

11.58

4993

33850

(3019069) Monocytes/Leukocytes in Blood

5181

35392

2.02

236.85

9.6

6.2

8.95

9.02

0.79

4941

32902

(3033658) Prothrombin time (PT) actual/Normal

3329

19556

2.08

230.24

7.8

3.9

85.97

86.63

0.83

3275

19136

(3006504) Eosinophils/Leukocytes in Blood

5148

35305

2.00

230.17

9.5

6.1

2.49

2.84

24.55

4908

32817

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1319

5180

2.79

229.65

11.3

9.4

0.68

0.63

3.77

1309

5140

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

652

1663

4.13

227.21

5.1

3.5

449.79

1270.45

u/ml

1.20

606

1522

(3018095) Leukocytes [#/volume] in Urine

4491

29500

1.99

225.88

5.8

3.8

148.16

123.30

e6/l

0.83

3577

20795

(36304419) Bacteria [Presence] in Urine

3553

21504

2.04

225.33

4.5

3.1

0.00

28.06

estimate

0.68

116

(3022096) Basophils/Leukocytes in Blood

5125

35341

1.98

222.67

9.6

6.2

0.61

0.66

10.19

4889

32826

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1338

5377

2.73

222.41

11.2

9.1

1.26

1.33

1.96

1328

5341

(3000570) Elastase.pancreatic [Mass/mass] in Stool

651

1686

4.07

222.10

1.5

1.4

226.35

267.16

ug/g

4.65

409

1029

(3002030) Lymphocytes/Leukocytes in Blood

5207

36165

1.97

220.81

9.6

6.1

24.23

26.62

42.53

5018

33977

(3018010) Neutrophils/Leukocytes in Blood

5100

35287

1.96

217.40

9.3

6.0

60.55

58.19

33.63

4945

33512

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1201

4674

2.80

211.82

11.2

9.4

15.54

16.06

8.74

1170

4484

(40768797) Stomach Pathology biopsy report

1838

8801

2.35

209.60

1.4

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2078

10631

2.22

201.46

2.2

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4588

31198

1.91

199.97

5.4

3.8

34.37

78.65

ng/l

2.68

3762

23500

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

969

3481

2.98

197.53

2.2

1.9

2.84

2.27

ug/l

0.58

877

3056

(3025941) Bacteria identified in Stool by Culture

895

3079

3.10

196.82

1.5

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4763

32908

1.90

196.40

4.4

2.8

148.74

152.62

ug/l

0.35

4447

30238

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1967

9976

2.22

194.01

2.3

1.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1228

5168

2.58

184.00

4.2

3.2

125.33

128.35

g/l

4.23

1182

5025

(3018418) pH of Serum or Plasma

3787

24937

1.86

175.45

6.0

4.1

7.40

0.51

2899

17860

(3015377) Calcium [Moles/volume] in Serum or Plasma

4096

27664

1.84

174.71

5.7

3.5

2.33

2.36

mmol/l

28.63

3822

24995

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1041

4141

2.70

174.34

1.7

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

606

1786

3.55

170.68

1.5

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1156

4911

2.54

169.06

11.2

9.0

24.15

24.30

mmol/l

0.71

1136

4776

(3019060) Gas panel - Arterial blood

1191

5162

2.49

166.80

6.6

4.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1216

5346

2.46

165.03

9.7

6.5

24.72

24.62

mmol/l

0.36

1169

5099

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1044

4335

2.58

159.70

4.1

2.8

1.28

1.22

1.29

1038

4313

(3027945) Reticulocytes/Erythrocytes in Blood

1841

9859

2.07

153.92

2.8

2.4

1.83

1.77

1.69

1642

8718

(3007853) Bacteria identified in Skin by Aerobe culture

1716

8960

2.12

153.43

2.2

1.8

—

(4035726) Immunohistochemistry procedure

1445

7079

2.23

151.80

1.5

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

779

2870

2.87

150.30

3.2

2.8

0.33

0.36

iu/ml

1.51

415

1585

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2584

15739

1.88

147.73

2.1

1.7

1.71

1.42

mg/l

3.05

2194

12324

(3013005) Retinol [Moles/volume] in Serum or Plasma

179

214

8.50

138.21

4.0

1.5

1.97

umol/l

0.01

168

199

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2164

12722

1.91

136.39

2.6

2.0

30.24

29.81

1.93

2117

12374

(3018405) Lactate [Moles/volume] in Arterial blood

723

2722

2.79

133.50

5.7

4.0

1.42

1.41

mmol/l

0.04

700

2672

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1779

9880

1.98

132.27

4.2

4.4

233.66

252.70

u/l

6.12

1688

9363

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1304

6472

2.18

131.25

2.6

2.4

391.61

388.14

nmol/l

0.16

1207

5990

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

805

3255

2.61

129.00

9.3

3.6

102.92

90.65

u/ml

0.34

779

3135

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2306

14075

1.84

128.01

4.1

3.0

1.43

1.31

e6/l

0.21

1294

7474

(3009261) Glucose [Presence] in Urine by Test strip

5330

41033

1.68

127.70

6.0

3.8

0.01

0.29

estimate

1.00

1372

8292

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

396

1064

3.84

127.40

7.4

5.8

12.88

11.97

mg/l

3.11

366

979

(3021960) Folate [Moles/volume] in Serum or Plasma

3443

23630

1.72

127.34

2.1

1.7

20.25

19.89

nmol/l

0.71

3026

19837

(3023520) Reticulocytes [#/volume] in Blood

1459

7642

2.07

127.27

2.8

2.5

69.76

68.37

e9/l

0.67

1060

5648

(40758558) Short blood count panel - Blood

3368

23032

1.72

125.86

12.5

6.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2387

14810

1.82

125.16

2.0

1.7

1212.89

1161.55

nmol/l

1.78

1853

11117

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2143

12888

1.85

124.22

4.3

3.1

3.10

2.31

e6/l

1.95

1130

6272

(3021601) Nitrite [Presence] in Urine by Test strip

5237

40296

1.67

124.22

6.0

3.8

0.00

estimate

0.01

1401

8586

(3035350) Ketones [Presence] in Urine by Test strip

5281

40799

1.66

122.62

6.0

3.8

5.68

3.08

estimate

0.47

1425

8882

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

589

2080

2.95

122.20

2.9

2.5

3.67

3.62

g/l

0.30

575

1983

(3015736) pH of Urine

4363

32158

1.66

121.34

5.0

3.4

6.28

6.24

1.42

2490

17481

(40760892) CBC W Ordered Manual Differential panel - Blood

2500

15859

1.78

120.99

7.0

4.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1075

5095

2.25

120.69

2.0

1.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

958

4324

2.35

120.69

5.4

3.9

48.56

46.41

1.80

939

4261

(3027273) Bicarbonate [Moles/volume] in Venous blood

890

3915

2.40

118.78

4.6

3.3

25.30

25.21

mmol/l

0.26

856

3794

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5868

46862

1.66

117.09

5.1

3.1

64.73

52.29

u/l

10.73

5564

43283

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1122

5523

2.17

114.35

5.2

3.7

5.14

5.16

kpa

0.26

1081

5237

(3009343) pH of Capillary blood

1098

5364

2.18

114.06

5.1

3.7

7.41

7.42

0.46

956

4459

(3020891) Body temperature

885

3987

2.34

111.63

7.3

4.3

36.93

36.91

°c

0.66

875

3946

(3007930) Methemoglobin/Hemoglobin.total in Blood

817

3553

2.42

111.61

6.9

4.8

0.88

0.86

0.40

780

3348

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

327

843

3.98

111.42

5.2

3.5

12.45

19.27

nmol/l

0.30

318

825

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

127

130

9.88

110.40

3.4

3.9

7.50

8.22

mg/l

0.44

103

(3021589) Normoblasts [#/volume] in Blood

4520

34138

1.62

110.13

22.7

11.4

0.00

e9/l

0.53

3799

27687

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

868

3917

2.34

108.96

6.6

4.6

1.53

1.59

1.12

828

3699

(40768804) Tissue Pathology biopsy report

3996

29404

1.62

107.53

2.6

2.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2438

15803

1.73

107.19

4.8

3.9

307.00

502.16

ng/l

0.90

1984

13211

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

981

4699

2.21

106.69

5.0

3.5

2.12

1.99

mmol/l

0.44

729

3420

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4514

34277

1.60

106.09

3.4

2.3

75.58

78.37

nmol/l

7.89

4148

30542

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

609

2370

2.68

104.85

2.1

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2515

16554

1.71

104.02

5.3

3.0

2.47

2.46

mmol/l

6.79

2310

14782

(3047181) Lactate [Moles/volume] in Blood

609

2397

2.64

102.46

7.8

5.4

1.38

1.36

mmol/l

0.14

518

2109

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1512

8622

1.90

101.29

5.6

3.5

—

(4281824) Cell count and differential, peritoneal fluid

297

775

3.92

99.46

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

449

1541

3.01

97.71

1.3

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

1310

7208

1.95

97.45

5.0

4.2

0.97

0.00

557

2196

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

446

1533

3.00

96.79

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

448

1544

2.99

96.76

1.3

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4663

36201

1.56

95.94

2.7

2.1

87.91

94.87

pmol/l

21.71

2962

19013

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

164

270

6.16

94.90

19.3

19.0

6003.22

1374.24

nmol/l

0.53

156

262

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

111

119

9.42

93.25

2.5

3.0

119.93

122.19

au/ml

0.01

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

280

739

3.87

92.26

1.8

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3619

26693

1.57

92.07

3.5

3.2

1783.79

1666.03

ng/l

0.62

3187

23159

(3028626) Oxygen [Partial pressure] in Capillary blood

546

2155

2.63

91.16

4.6

3.2

8.03

7.97

kpa

0.36

533

2098

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

157

258

6.17

91.02

14.3

889.42

5898.25

nmol/l

0.49

150

245

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

283

760

3.81

90.96

1.8

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

463

1689

2.83

90.10

2.9

2.4

32.58

32.87

umol/l

0.09

413

1506

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

533

2098

2.63

89.45

2.8

2.3

87.29

91.54

3.45

526

2018

(3003181) Sodium [Moles/volume] in Urine

430

1514

2.93

89.31

2.2

1.3

59.36

62.90

mmol/l

0.83

312

1227

(3024522) Salmonella sp identified in Specimen by Organism specific culture

278

748

3.80

89.11

1.8

1.4

—

(3002256) Pathology report gross observation

1688

10337

1.77

88.45

1.4

—

(1616796) Gas panel - Central venous blood

498

1907

2.70

88.27

4.3

3.7

—

(3002179) Metamyelocytes/Leukocytes in Blood

1223

6830

1.91

86.28

4.8

4.0

0.74

0.71

0.15

496

2068

(3024928) Oxygen saturation in Venous blood

502

1966

2.64

85.05

3.6

3.0

60.36

60.84

0.17

481

1888

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2523

17351

1.62

84.84

2.0

1.7

7623538.40

25499938.13

pmol/l

2.14

2112

14114

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

494

1924

2.65

84.62

3.1

2.6

215.70

200.29

2.82

476

1838

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3446

25496

1.55

84.44

2.6

2.2

241.46

235.62

u/l

0.09

3273

23963

(3005988) Vibrio sp identified in Specimen by Organism specific culture

265

720

3.76

83.75

1.7

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

3167

23063

1.56

82.95

6.2

4.0

0.00

estimate

0.26

1275

7678

(3012501) Base excess in Blood by calculation

457

1729

2.72

82.88

5.2

3.9

2.96

2.64

mmol/l

1.21

332

1151

(3013290) Carbon dioxide [Partial pressure] in Blood

457

1730

2.72

82.78

5.2

3.9

5.00

4.99

kpa

0.11

448

1684

(3015235) Bicarbonate [Moles/volume] in Capillary blood

657

2958

2.31

82.22

3.6

3.0

24.75

24.82

mmol/l

0.14

641

2903

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

263

720

3.73

82.20

1.7

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

457

1738

2.71

82.03

5.2

3.9

8.78

8.50

kpa

2.16

448

1691

(3025468) Yersinia sp identified in Specimen by Organism specific culture

262

720

3.71

81.43

1.7

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

21.15

81.32

2.0

2.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1190

6728

1.88

80.46

1.7

1.5

—

(3010421) pH of Blood

605

2653

2.37

80.42

5.0

3.6

7.41

0.07

596

2611

(3007164) IgA [Mass/volume] in Serum or Plasma

1875

12111

1.68

80.09

1.6

1.5

2.66

2.57

g/l

0.61

1224

7300

(3043409) Potassium [Moles/volume] in Arterial blood

545

2288

2.46

79.79

6.3

4.3

3.83

3.91

mmol/l

3.45

536

2264

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2061

13654

1.65

79.78

1.3

1.76

1.95

u/ml

0.22

553

3598

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

404

1468

2.83

79.10

6.4

5.1

1169.37

1472.08

iu/ml

0.10

211

(3021440) Promyelocytes/Leukocytes in Blood

1210

6917

1.86

78.91

5.2

4.2

0.10

0.12

0.53

459

1918

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

787

3877

2.12

78.76

1.7

1.6

1.69

1.55

g/l

3.57

690

3277

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3946

30400

1.51

78.34

6.1

3.8

0.06

0.36

estimate

1.43

1179

6966

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1355

8079

1.79

76.82

1.7

1.5

—

(3017732) Neutrophils [#/volume] in Blood

1500

9228

1.74

76.24

5.0

3.1

4.77

4.67

e9/l

0.16

1318

7868

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

495

2036

2.51

75.66

1.7

1.5

7.54

5.01

iu/ml

0.13

417

(3037121) Protein [Mass/volume] in Urine

586

2611

2.33

74.99

4.9

3.1

425.62

403.60

mg/l

0.04

396

1150

(3021901) Oxygen saturation in Capillary blood

460

1848

2.56

73.86

3.4

2.9

89.31

89.22

0.10

448

1791

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6481

55632

1.52

73.54

5.6

4.2

16.36

13.35

mm/h

34.80

6074

51476

(3020630) Protein [Mass/volume] in Serum or Plasma

1234

7243

1.81

73.50

3.1

2.5

65.07

66.17

g/l

4.38

1138

6552

(3025159) Blasts/Leukocytes in Blood

1193

6946

1.82

72.95

5.5

4.3

0.06

0.42

2.90

433

1796

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8153

73882

1.73

72.86

41.1

15.8

33.36

26.61

mg/l

56.72

7755

60947

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

104

140

7.50

72.69

3.2

1.8

9.09

9.20

mg/l

0.07

121

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

186

445

4.24

70.08

1.5

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1147

6683

1.81

69.77

3.2

2.5

0.65

0.49

e6/l

1.17

1117

6425

(3036489) Thrombin time

580

2652

2.26

69.73

2.7

2.0

21.37

21.15

0.26

543

2380

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

188

457

4.17

69.36

1.5

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1204

7200

1.77

66.89

2.7

2.3

4.95

7.79

ug/l

9.85

1043

6258

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

347

1274

2.79

66.56

1.5

1.4

273.41

205.85

pmol/l

1.00

337

1238

(3005719) IgG [Mass/volume] in Serum or Plasma

966

5414

1.87

66.41

2.8

2.9

10.41

10.70

g/l

0.81

887

4965

(3003327) Ova and parasites identified in Stool by Light microscopy

423

1720

2.53

66.15

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

436

1802

2.49

65.86

3.1

2.6

15.75

16.32

3.35

429

1761

(3039000) Anion gap in Blood by calculation

421

1715

2.52

65.58

9.4

6.2

11.26

11.32

mmol/l

0.14

388

1527

(3018572) Chloride [Moles/volume] in Blood

421

1716

2.52

65.50

9.4

6.2

104.91

105.00

mmol/l

0.13

389

1528

(3000494) Fungus identified in Specimen by Culture

1395

8764

1.69

64.75

1.9

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1459

9276

1.68

64.73

1.9

1.7

—

(40761536) Microorganisms panel - Urine sediment

1065

6220

1.80

63.95

6.2

3.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

613

2968

2.14

63.81

2.4

2.2

554.17

655.73

ug/l

0.39

587

2824

(3041096) Erythrocytes [Presence] in Urine by Automated

2829

21070

1.49

62.46

5.4

3.4

0.03

0.26

estimate

2.13

1149

6659

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

8.41

62.46

2.3

1.6

107.43

172.61

au/ml

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

468

2058

2.34

61.56

1.8

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4739

39047

1.43

60.41

3.1

2.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

777

4196

1.93

59.61

2.0

1.9

1.33

1.34

g/l

0.04

719

3797

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1130

6929

1.72

56.84

5.3

3.8

1.22

1.23

mmol/l

6.08

1005

5869

(3052851) Hemolysis interference index of Serum or Plasma

462

2104

2.26

55.91

4.8

3.3

2.11

2.19

index

0.09

280

1075

(3022313) Gas panel - Capillary blood

692

3706

1.93

54.27

5.7

3.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

569

2845

2.06

54.23

2.2

1.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

223

721

3.14

53.72

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1003

6051

1.73

53.32

4.9

3.7

104.66

92.16

ng/l

2.81

846

5116

(3010015) Selenium [Moles/volume] in Serum or Plasma

11.79

53.13

2.8

1.4

1.19

1.38

umol/l

1.94

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

131

297

4.46

52.96

1.3

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

601

3098

2.00

52.62

2.4

1.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

453

2100

2.21

52.47

1.9

1.5

—

(40762365) Oxygen content in Arterial blood by calculation

116

6.94

52.35

3.5

3.0

14.20

14.77

ml/dl

0.81

106

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

129

292

4.46

52.26

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

130

304

4.32

50.53

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

130

304

4.32

50.53

1.6

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

314

1259

2.54

50.52

1.6

1.4

—

(3003694) ABO and Rh group [Type] in Blood

2700

20598

1.43

50.19

1.5

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

2676

20382

1.43

50.19

4.2

2.9

0.12

0.06

0.76

646

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

398

1783

2.29

50.05

1.6

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

502

2472

2.09

49.79

1.4

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2476

18674

1.44

48.71

5.4

3.7

0.29

0.16

0.43

247

(3006184) Hemoglobin [Mass/volume] in Capillary blood

433

2044

2.17

47.90

2.7

2.3

124.04

128.64

g/l

3.37

367

1593

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

333

1416

2.40

47.20

1.8

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

349

1518

2.35

47.00

1.6

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

133

337

3.99

46.48

3.5

1.3

17.21

23.49

umol/l

1.90

125

308

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

345

1523

2.31

44.90

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

355

1593

2.28

44.46

1.7

1.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

187

634

2.99

41.56

1.1

1.76

1.38

iu/ml

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

105

244

4.34

41.21

2.7

2.6

0.61

0.62

mmol/l

0.45

105

244

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

547

2986

1.88

40.24

3.7

3.3

47.32

46.99

mg/l

0.02

455

2507

(3034860) Kappa light chains.free [Mass/volume] in Serum

547

2986

1.88

40.24

3.7

3.3

85.05

55.99

mg/l

1.29

457

2504

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

529

2868

1.89

39.75

6.2

3.9

24.75

24.90

mmol/l

0.45

485

2588

(3004809) Band form neutrophils/Leukocytes in Blood

311

1385

2.29

39.66

3.6

1.66

1.48

0.36

285

1215

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

259

1065

2.47

39.53

1.7

1.4

—

(3008295) Osmolality of Serum or Plasma

219

832

2.67

39.36

1.4

275.66

278.42

mosm/kgh2o

0.82

162

638

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

273

1159

2.39

38.86

3.4

2.6

1178.25

2075.61

u/ml

0.39

(3019150) Specific gravity of Urine by Refractometry

2313

17818

1.39

38.71

6.0

4.1

1.02

1.10

kg/l

0.50

1719

11797

(3021162) Amylase [Enzymatic activity/volume] in Specimen

143

5.35

38.35

2.6

3.0

1330.32

2090.00

u/l

0.28

131

(3021879) Hepatitis B virus core Ab [Presence] in Serum

758

4626

1.69

38.11

1.4

—

(3016038) Potassium [Moles/volume] in Urine

163

538

3.06

38.00

2.5

1.1

34.31

35.24

mmol/l

0.18

149

459

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

548

3048

1.85

37.98

2.6

—

(3013512) EKG study

3469

28547

1.34

37.89

4.6

3.7

0.69

0.79

0.38

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

615

3547

1.78

37.81

2.3

2.4

—

(3044889) 12 lead EKG panel

6089

54375

1.33

37.07

5.2

4.3

0.57

2493.21

0.54

133

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

252

1064

2.40

36.32

1.7

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

377

1881

2.04

36.02

1.6

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

255

1089

2.38

35.84

1.4

1.6

0.63

0.88

g/l

3.20

182

832

(3019550) Sodium [Moles/volume] in Serum or Plasma

8201

76971

1.48

35.77

46.0

19.5

138.83

139.69

mmol/l

145.03

8096

75288

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

485

2665

1.86

34.91

3.5

3.2

6.50

5.75

ratio

0.08

268

1560

(3017315) Amylase [Enzymatic activity/volume] in Urine

110

302

3.67

34.40

1.7

1.2

225.39

460.85

u/l

1.57

102

275

(3037522) Nuclear Ab [Titer] in Serum

1325

9403

1.47

34.39

1.4

1.3

520.51

480.95

titre

0.34

315

2078

(3007566) Smooth muscle Ab [Titer] in Serum

367

1845

2.03

34.35

1.3

1.2

127.00

172.51

titre

0.45

179

(3023103) Potassium [Moles/volume] in Serum or Plasma

8201

77119

1.46

33.93

46.1

19.7

3.96

3.99

mmol/l

19.92

8089

75297

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

143

476

3.03

32.90

2.5

1.7

—

(3008037) Lactate [Moles/volume] in Venous blood

412

2194

1.92

32.65

4.1

3.1

1.54

1.67

mmol/l

1.81

403

2133

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

237

1024

2.35

32.46

2.4

2.1

2187.16

5061.96

u/l

1.09

392

(3034770) Mitochondria Ab [Titer] in Serum

356

1832

1.98

31.20

1.3

1.2

693.33

925.93

titre

—

(3044242) Glucose [Moles/volume] in Arterial blood

141

482

2.95

30.98

3.2

1.8

7.91

8.36

mmol/l

0.78

141

482

(40768441) Liver Pathology biopsy report

150

536

2.83

30.41

1.5

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

174

672

2.62

30.35

1.7

1.5

—

(3049717) Cytology report of Urine Cyto stain

552

3298

1.71

29.88

2.9

2.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

230

1020

2.28

29.69

6.6

6.3

7.18

7.44

mmol/l

0.64

208

851

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1013

7011

1.50

29.50

3.2

3.0

220.03

229.34

ng/l

0.27

932

6453

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

183

4.23

29.45

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

244

1114

2.22

29.37

1.3

263.47

281.79

u/ml

0.37

152

680

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

115

364

3.18

28.87

3.5

3.6

1.11

1.27

0.55

115

364

(40761535) Cells panel - Urine sediment

902

6123

1.52

28.79

4.6

3.3

—

2.40

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

186

761

2.47

28.79

1.4

1.2

56.24

63.75

u/l

1.14

171

652

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

178

714

2.52

28.74

3.4

2.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

321

1642

1.99

28.64

1.2

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

426

2393

1.82

28.54

4.6

3.2

1.76

1.61

mg/l

2.55

393

2120

(3044007) Cell count panel - Peritoneal fluid

264

3.58

28.49

1.7

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

256

3.62

28.27

5.2

2.4

10.42

10.02

kpa

0.65

256

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

561

3425

1.68

28.00

2.8

2.2

7.45

7.41

g/l

0.22

519

3092

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

253

1195

2.15

27.99

1.2

1.3

45.77

122.84

u/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

559

3411

1.68

27.96

2.8

2.2

3.78

3.76

g/l

0.05

517

3083

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

559

3420

1.67

27.67

2.8

2.2

4.23

4.19

g/l

0.44

517

3091

(3023487) Leukocytes [#/volume] in Peritoneal fluid

102

308

3.34

27.66

2.1

1.8

1043.98

5018.16

e6/l

0.69

203

(3017569) Oxygen content in Arterial blood

137

491

2.82

27.66

3.2

2.1

15.29

15.87

0.95

137

491

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

323

1677

1.96

27.61

1.5

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

256

3.58

27.53

5.3

2.4

5.02

4.94

kpa

0.25

256

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

322

1677

1.95

27.28

1.5

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

345

1841

1.91

27.19

4.4

3.2

7.46

7.79

mmol/l

1.49

337

1792

(40757494) Bilirubin.total [Moles/volume] in Blood

113

370

3.08

26.83

3.2

2.2

16.36

37.83

umol/l

1.11

(3000012) Reticulocyte production index

271

1341

2.05

26.54

2.2

0.86

0.92

1.04

213

899

(3009466) Valproate [Moles/volume] in Serum or Plasma

226

1054

2.17

25.85

6.4

4.8

350.89

356.89

umol/l

0.24

206

895

(3028192) IgG subclass 2 [Mass/volume] in Serum

166

680

2.47

25.67

1.3

1.4

2.64

3.02

g/l

1.92

108

484

(3024139) IgG subclass 3 [Mass/volume] in Serum

166

680

2.47

25.67

1.3

1.4

0.43

0.44

g/l

0.07

108

479

(3027135) IgG subclass 1 [Mass/volume] in Serum

166

681

2.46

25.60

1.3

1.4

6.82

6.94

g/l

0.11

108

482

(4062490) Immunoglobulin typing, IgG

164

670

2.47

25.52

1.3

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

534

3307

1.65

25.20

1.5

1.6

9.39

17.63

iu/ml

1.16

(3026250) Tacrolimus [Mass/volume] in Blood

258

3.43

25.03

52.6

37.7

6.91

7.27

ug/l

0.88

233

(3001186) Copper [Moles/volume] in Serum or Plasma

154

4.24

25.01

2.0

1.1

15.50

16.63

umol/l

0.93

135

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6579

60627

1.28

24.97

47.6

19.9

14.39

13.74

189.10

6532

59691

(3037756) Immunofixation for Serum or Plasma

334

1815

1.87

24.90

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

120

427

2.83

24.60

1.5

1.2

122.24

93.10

u/l

1.18

107

350

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

520

3219

1.65

24.58

2.9

2.3

2.99

2.92

g/l

0.87

477

2887

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

485

2957

1.67

24.31

2.9

2.2

10.00

10.26

g/l

0.59

435

2591

(3004451) EKG impression Narrative

130

493

2.66

23.61

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

140

554

2.55

23.33

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

710

4788

1.52

23.23

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

130

499

2.63

23.06

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

210

999

2.13

22.88

1.8

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

210

999

2.13

22.88

1.8

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

210

999

2.13

22.88

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

210

999

2.13

22.88

1.8

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

115

417

2.78

22.79

1.5

1.2

53.94

26.44

u/l

1.72

101

332

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

899

6387

1.45

22.66

4.1

2.8

62.29

62.40

ml/min/173m2

0.03

436

2670

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

261

3.28

22.52

2.0

1.7

6564.32

13988.92

e6/l

0.41

135

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

231

1146

2.04

22.52

1.4

158.93

152.43

au/ml

0.33

362

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

341

1926

1.80

22.47

1.7

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

248

1265

1.99

22.37

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

173

769

2.27

22.31

5.5

3.3

12.26

12.76

index

0.27

131

398

(3045414) Leukocytes [Presence] in Urine

1013

7377

1.42

22.28

2.8

2.1

0.03

0.01

estimate

0.52

198

1448

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

247

1260

1.99

22.28

1.4

24.55

16.84

u/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

154

654

2.38

22.07

2.1

1.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

454

2791

1.66

22.05

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

125

484

2.60

21.81

1.6

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

194

3.63

21.73

2.8

1.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

7557

71249

1.29

21.69

37.5

16.2

77.00

76.49

ml/min/173m2

1.23

7257

66169

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

304

3.04

21.59

3.4

1.8

89.93

110.32

umol/l

0.46

157

(3026493) Urate [Moles/volume] in Serum or Plasma

2506

20924

1.27

21.37

3.5

2.8

351.97

352.66

umol/l

0.10

2156

18213

(3042631) Mycobacterium sp identified in Specimen

232

1179

1.99

21.17

2.4

2.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1009

7420

1.40

20.92

1.9

1.7

1.62

1.51

3.75

852

6405

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

192

921

2.11

20.52

1.2

1.1

1.59

1.53

g/l

1.16

176

824

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

178

833

2.16

20.28

1.4

1.3

0.20

0.22

nmol/l

0.26

140

667

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

140

4.02

20.13

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

324

2.89

19.91

3.0

4.3

1775.43

877.76

mg/l

0.20

216

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

148

647

2.31

19.90

1.7

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

326

1884

1.76

19.89

1.4

1.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

185

886

2.11

19.87

3.2

3.4

59.81

58.19

0.49

162

749

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

198

974

2.05

19.80

1.4

1.3

0.13

0.26

nmol/l

1.80

(3023419) Bacteria identified in Sputum by Culture

214

1083

2.00

19.79

3.1

2.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

175

823

2.15

19.70

3.7

4.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

261

1415

1.87

19.67

1.4

31.87

31.77

g/l

0.04

235

1270

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

193

949

2.05

19.33

1.4

1.3

4.96

5.23

nmol/l

0.02

186

916

(40761539) Cells [Type] in Urine sediment by Light microscopy

181

3.55

19.32

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

342

2023

1.72

19.22

1.4

1.6

0.24

g/l

0.38

326

1916

(3016650) Hepatitis A virus Ab [Presence] in Serum

217

1116

1.97

19.18

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

473

3051

1.58

18.88

1.1

1.05

8.34

u/ml

0.54

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

15.83

18.74

1.0

1.1

47.56

40.80

u/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

110

434

2.55

18.54

1.9

1.5

4.89

6.24

u/l

0.61

340

(3010375) cycloSPORINE [Mass/volume] in Blood

267

3.01

18.51

25.9

28.0

120.03

112.33

ug/l

0.35

230

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

169

804

2.12

18.50

1.4

1.3

—

nmol/l

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

462

2993

1.57

18.10

2.8

2.4

1.17

0.95

g/l

0.34

397

2517

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

347

2098

1.68

18.00

1.4

1.6

1.21

1.19

g/l

0.50

330

1994

(3020961) Endomysium IgA Ab [Titer] in Serum

416

2646

1.60

17.63

1.1

137.14

171.13

titre

—

(3045424) Erythrocytes [Presence] in Urine

553

3756

1.50

17.44

2.8

2.1

0.01

0.02

estimate

0.14

164

1123

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

397

2509

1.61

17.29

2.8

2.3

0.05

0.03

g/l

0.32

356

2226

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6079

56442

1.21

17.16

4.7

4.1

14.98

14.97

pmol/l

0.17

5506

51170

(3006922) Hepatitis E virus Ab [Presence] in Serum

114

479

2.40

16.84

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

117

498

2.37

16.79

2.2

2.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

254

1439

1.79

16.65

1.5

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8249

79259

1.31

16.62

49.1

21.5

83.69

81.00

umol/l

5.87

8155

78115

(3028707) Methadone [Presence] in Urine by Screen method

140

647

2.18

16.54

4.0

2.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

104

424

2.47

16.42

1.2

80.31

76.86

0.17

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

209

1122

1.88

16.31

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

382

2427

1.60

16.29

2.8

2.2

0.00

g/l

0.79

337

2086

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

136

627

2.19

16.18

1.2

—

(3011412) CD3 cells [#/volume] in Blood

137

636

2.17

16.02

2.2

2.4

1049.75

1152.48

e6/l

0.77

125

568

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

356

2243

1.61

15.73

2.9

2.3

0.00

g/l

-0.00

336

2083

(3052592) Norovirus Ag [Presence] in Stool

138

3.64

15.71

1.6

1.3

—

(21494755) Public health laboratory ask at order entry panel

307

4900

0.61

15.66

1.2

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8133

78108

1.28

15.65

22.6

11.7

25.11

26.09

u/l

4.63

7977

75277

(3034274) Bile acid [Moles/volume] in Serum --fasting

399

2.47

15.54

2.7

2.0

13.11

12.02

umol/l

0.09

280

(3023199) Leukocytes [#/volume] in Pleural fluid

221

1236

1.81

15.17

1.5

1.4

1781.79

2924.68

e6/l

0.68

158

879

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

136

646

2.12

15.03

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

136

646

2.12

15.03

1.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

136

646

2.12

15.03

1.8

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

400

2622

1.55

14.92

1.8

1.6

0.41

0.31

mg/l

1.96

184

1221

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

409

6055

0.66

14.79

2.0

2.1

3.35

3.47

ratio

1.20

333

4789

(3045788) Cell count panel - Pleural fluid

188

1010

1.88

14.69

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

242

1405

1.74

14.63

1.3

1.2

—

(3011985) Renin [Units/volume] in Plasma

190

1026

1.87

14.61

1.6

1.4

43.88

73.10

mu/l

1.50

167

922

(3005322) IgE [Units/volume] in Serum or Plasma

562

3965

1.44

14.61

1.4

1.3

175.00

269.44

u/ml

2.73

528

3661

(40768806) Pleura Pathology biopsy report

198

1084

1.84

14.58

1.5

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2768

31448

0.83

14.47

2.1

1.9

1.44

1.33

mmol/l

8.25

2244

25922

(3021788) Differential panel - Synovial fluid

246

1443

1.72

14.35

1.5

—

1.00

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

162

3.28

14.29

1.9

2.5

3.77

79.31

ug/l

1.45

162

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

5.66

14.11

1.5

1.2

426.57

2165.85

u/l

0.52

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

396

2625

1.53

14.05

1.1

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

185

3.09

13.93

1.5

1.3

32.28

26.42

g/l

2.10

143

(3041672) Baker's yeast Ab [Presence] in Serum

12.65

13.85

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

176

944

1.88

13.85

1.3

1.4

6.06

6.39

mmol/l

0.81

161

869

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

179

966

1.87

13.82

1.3

355.27

317.53

pmol/l

0.20

148

811

(3000330) Specific gravity of Urine by Test strip

577

4133

1.42

13.81

5.3

3.3

1.02

ratio

0.31

524

3750

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

342

2203

1.57

13.80

1.7

1.6

19.43

21.58

u/ml

0.16

506

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

274

4355

0.62

13.73

1.7

1.8

3.32

3.45

mmol/l

0.97

196

3076

(3001893) Eosinophils/Leukocytes in Pleural fluid

293

2.61

13.55

1.4

1.77

2.56

0.49

254

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

414

2.33

13.47

2.1

2.8

212.87

247.49

e6/l

0.85

357

(3026692) Albumin [Mass/volume] in Peritoneal fluid

216

2.88

13.41

1.9

1.3

16.27

13.39

g/l

1.73

167

(3010370) Gastrin [Moles/volume] in Serum or Plasma

3.93

13.38

2.0

1.8

86.21

57.44

pmol/l

0.40

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

404

2.34

13.30

1.9

2.7

499.96

541.15

e6/l

0.33

330

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

11.45

13.25

1.1

1.4

175.67

418.95

umol/l

0.60

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

411

2.32

13.24

1.1

—

0.62

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

109

501

2.19

13.16

2.1

16.22

16.02

0.07

109

491

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

151

784

1.94

13.13

2.0

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

327

2114

1.57

13.01

6.1

3.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

195

1102

1.78

12.99

1.4

27784.51

49720.16

e6/l

1.33

116

633

(3006576) Bicarbonate [Moles/volume] in Blood

248

2.71

12.96

6.1

25.63

24.53

mmol/l

0.74

220

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

137

3.37

12.95

1.5

1.2

—

(4198724) Urine methamphetamine measurement

188

2.99

12.95

5.7

1.6

—

(3019225) pH of Specimen

976

7661

1.30

12.94

5.9

4.0

7.36

0.27

790

5401

(3005532) Lymphocytes/Leukocytes in Pleural fluid

344

2.42

12.75

1.4

62.68

66.13

0.39

289

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

224

2.78

12.57

1.2

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

120

584

2.07

12.53

1.8

1.3

1.25

1.18

promille

0.19

461

(3009214) Lutropin [Units/volume] in Serum or Plasma

243

1486

1.65

12.19

1.4

11.80

10.65

u/l

0.62

206

1182

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

242

1484

1.65

12.01

1.2

1.3

333.21

290.30

titre

0.08

115

(21494890) Protein electrophoresis panel - 24 hour Urine

156

851

1.85

11.71

1.9

2.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

114

561

2.04

11.59

1.3

1.2

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

265

2.54

11.41

1.3

1.4

22.69

18.89

0.52

243

(3000475) Leukocytes [#/volume] in Synovial fluid

298

1946

1.55

11.38

1.6

17205.84

13524.87

e6/l

0.54

215

1355

(3024891) Influenza virus A+B Ag [Presence] in Specimen

266

1698

1.58

11.23

1.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

384

2.25

11.21

2.7

2.8

37.97

36.54

0.29

203

(4024509) Urine culture

485

3516

1.40

10.87

2.6

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

137

738

1.87

10.74

2.0

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

166

949

1.76

10.71

1.3

337.67

466.56

u/l

0.83

153

906

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

224

1393

1.62

10.57

1.1

1.02

10.36

eliau/ml

4.63

151

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

140

3.08

10.54

1.4

1.5

12.15

12.07

0.01

(3022621) pH of Urine by Test strip

762

5951

1.30

10.46

3.7

2.6

6.07

6.05

0.18

575

4179

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

431

3083

1.42

10.44

1.7

1.9

38.55

38.93

u/l

0.14

376

2688

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.41

10.38

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

253

1629

1.57

10.33

1.6

1.4

7.04

29.40

e6/l

3.11

197

1224

(3003129) Base excess in Capillary blood by calculation

161

926

1.75

10.20

2.7

2.4

0.75

0.47

mmol/l

0.32

151

891

(3035947) Staphylolysin Ab [Units/volume] in Serum

330

2.28

10.16

1.2

1.1

4.75

3.25

iu/ml

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

7.43

10.14

1.9

3.0

2.02

2.53

mg/l

0.44

(3045142) Bone marrow Pathology biopsy report

164

950

1.74

10.14

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

317

2153

1.49

10.11

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

393

2782

1.43

10.10

1.5

1.7

5.77

6.53

iu/ml

0.31

639

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1904

0.51

10.06

1.1

1.2

1.49

1.52

g/l

0.66

1904

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

370

2.20

10.04

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

370

2.20

10.04

2.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

370

2.20

10.04

2.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

371

2.19

9.97

2.0

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

392

2.15

9.88

2.6

2.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

208

2.60

9.76

1.6

1.3

139.16

125.15

nmol/l

0.21

152

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1766

0.50

9.75

1.1

0.60

0.61

ratio

0.09

276

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

253

1652

1.55

9.73

1.6

1.5

666.19

1257.79

e6/l

1.02

212

1320

(3007461) Platelets [#/volume] in Blood

8266

80286

1.22

9.69

57.4

24.2

256.74

244.45

e9/l

40.71

8145

78197

(3042733) HLA Ab [Presence] in Serum

175

2.75

9.66

4.1

4.7

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

8266

80302

1.22

9.57

57.2

24.1

91.44

91.52

0.88

8185

79152

(3035941) MCH [Entitic mass]

8266

80302

1.22

9.57

57.1

24.1

30.20

30.43

22.95

8183

79154

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

8266

80306

1.22

9.54

58.6

24.7

38.13

40.49

54.25

8182

79122

(3026361) Erythrocytes [#/volume] in Blood

8266

80307

1.22

9.53

57.3

24.2

4.24

4.46

e12/l

239.54

8125

77896

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

105

540

1.95

9.52

1.2

126.07

168.31

titre

0.36

(3000963) Hemoglobin [Mass/volume] in Blood

8266

80320

1.22

9.44

57.9

24.4

126.41

134.74

g/l

307.65

8192

79191

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

413

2.09

9.42

2.0

1.9

2.81

2.77

u/field

0.02

284

(3010813) Leukocytes [#/volume] in Blood

8266

80324

1.22

9.41

57.4

24.2

7.24

6.83

e9/l

33.15

8128

77914

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

128

707

1.82

9.33

1.9

2.0

1.98

1.61

u/field

0.54

371

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

123

672

1.84

9.29

2.0

1.7

5.01

4.03

mg/l

1.22

115

646

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

422

2.07

9.28

1.3

1.1

27.00

26.48

u/l

0.03

370

(3014271) Vancomycin [Susceptibility]

436

2.05

9.25

3.7

2.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

139

790

1.77

9.22

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

232

2.46

9.22

1.7

2.4

32.05

30.67

0.24

221

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

491

1.98

9.21

1.1

1.0

305.45

290.80

mg/l

0.89

443

(3015171) Extractable nuclear Ab [Units/volume] in Serum

359

2545

1.43

9.19

1.2

1.14

1.21

u/ml

0.03

210

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

424

2.06

9.17

1.3

1.1

88.48

85.44

u/l

0.10

375

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

372

2.13

9.12

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

372

2.13

9.12

1.3

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

426

2.05

9.06

3.4

3.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

163

975

1.68

9.02

1.3

—

(1761868) Lipid panel - Serum or Plasma

2369

26468

0.86

8.96

3.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

18.59

8.92

2.9

4.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

423

2.04

8.86

1.3

1.4

1.19

1.26

nmol/l

0.23

320

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

173

1057

1.65

8.83

1.8

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

282

1928

1.48

8.76

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

124

694

1.80

8.69

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.24

8.59

15.7

10.2

5.04

5.35

mmol/l

0.34

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

175

1082

1.63

8.54

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

132

2.88

8.40

2.2

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

171

1057

1.63

8.37

2.3

2.4

0.94

1.21

g/24h

0.86

105

618

(3035880) pH of Pleural fluid

509

1.91

8.34

1.3

7.42

7.41

0.18

349

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

270

1850

1.47

8.31

1.5

1.4

520.34

581.49

mg/l

1.02

259

1763

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

244

1643

1.50

8.20

1.4

1.3

3.87

3.85

mmol/l

0.13

224

1556

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

429

1.99

8.19

2.2

2.7

0.59

0.64

e9/l

0.44

407

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

221

2.40

8.18

2.5

2.3

129.67

145.18

nmol/l

0.76

197

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

240

1612

1.50

8.16

1.2

1.90

5.06

u/ml

—

113

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

113

3.01

8.12

1.2

82.80

74.69

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1150

9690

1.21

8.11

14.3

7.0

—

(3020393) Adenovirus Ag [Presence] in Stool

3.57

8.10

1.2

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.38

8.05

2.2

2.1

17.02

18.89

umol/l

0.39

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

107

587

1.83

8.04

1.6

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

549

4255

1.31

8.00

3.2

3.5

4.32

4.43

pmol/l

2.41

481

3768

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

261

2.27

7.98

2.2

1.7

3658.25

81334.69

u/ml

1.02

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

159

2.65

7.93

1.2

1.3

94.14

85.79

0.56

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

126

735

1.72

7.71

1.2

1.3

15.46

13.10

u/l

0.29

114

680

(3042517) Benzodiazepines panel - Urine

6.34

7.69

2.2

1.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

187

1209

1.56

7.62

4.0

45.34

39.34

u/ml

0.26

182

1175

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

163

2.58

7.56

1.2

1.1

94.71

86.91

0.74

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

107

599

1.79

7.55

1.3

1.2

112.64

108.46

pmol/l

0.09

107

599

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7100

68434

1.15

7.50

5.8

5.1

2.01

2.00

mu/l

0.07

6457

62458

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

251

2.24

7.38

1.9

2.1

177.94

159.05

0.55

235

(3006270) Folate [Moles/volume] in Blood

108

611

1.78

7.37

1.2

328.51

348.45

nmol/l

0.47

489

(3028717) Thiamine [Mass/volume] in Blood

3.04

7.28

1.2

60.50

62.92

ug/l

0.35

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

154

963

1.61

7.25

1.2

3.44

3.64

u/ml

0.06

323

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.06

7.13

2.1

1.6

1.25

1.34

mmol/l

0.06

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1424

12369

1.18

7.11

1.3

32.01

37.90

iu/ml

0.68

439

3800

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.12

7.11

4.5

5.9

4958.00

5742.00

iu/ml

—

(3002619) Bacteria identified in Specimen by Culture

200

2.36

7.00

1.4

1.3

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

3.49

6.97

3.0

2.1

56.53

66.90

0.58

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

113

2.84

6.92

1.3

111.09

78.62

1.86

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

276

1970

1.41

6.90

1.7

1.9

12.22

12.31

mg/l

0.05

248

1836

(3016244) Insulin [Units/volume] in Serum or Plasma

299

2.08

6.83

2.7

3.2

25.51

23.44

mu/l

0.16

284

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1086

9258

1.19

6.73

1.5

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

226

1569

1.45

6.59

1.9

1.8

372.83

304.36

mu/l

0.71

213

1439

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

133

824

1.62

6.55

4.3

3.6

—

(21494434) Karyotype in Bone marrow

118

709

1.67

6.55

1.1

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

265

1898

1.41

6.52

1.2

1.3

7.34

6.16

u/ml

0.10

280

(3017704) Immunofixation for Urine

454

1.83

6.39

2.0

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

119

722

1.66

6.37

1.3

1.4

126836.48

155886.34

e6/l

0.17

478

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

190

2.32

6.37

1.8

2.2

195.85

195.18

0.01

182

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

263

1890

1.40

6.36

1.2

1.3

12.09

3.42

u/ml

0.39

188

(3006442) Creatine [Moles/volume] in Serum or Plasma

450

1.83

6.26

1.7

1.6

94.73

86.63

umol/l

0.59

450

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

137

2.56

6.25

1.3

1.4

1.19

1.17

mmol/l

0.67

137

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

2.94

6.24

2.0

2.4

149.70

68.21

pmol/l

0.41

(3009508) Creatinine [Moles/volume] in Urine

3123

28860

1.12

6.22

3.6

3.4

7.32

7.45

mmol/l

0.87

2628

24010

(1001926) Buprenorphine [Presence] in Urine by Screen method

179

1204

1.50

6.16

3.9

1.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.16

5.99

1.4

1.2

439.65

330.00

umol/24h

0.57

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

274

2004

1.38

5.99

1.3

1.2

10.92

34.38

u/ml

2.55

105

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

5.98

1.2

1.3

—

(40768795) Lymph node Pathology biopsy report

130

828

1.58

5.76

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

145

949

1.54

5.71

1.3

1.2

4.50

4.40

u/ml

0.04

425

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

136

878

1.56

5.69

1.1

116.47

115.68

0.09

126

780

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

392

1.84

5.67

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

115

717

1.61

5.59

1.6

1.5

29.15

27.21

0.23

430

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.36

5.52

2.9

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

110

681

1.62

5.50

1.1

92.32

97.03

1.05

104

637

(4268621) Lupus anticoagulant assay

108

667

1.63

5.46

2.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

178

2.25

5.46

1.8

1.6

0.46

0.36

ug/l

0.48

113

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

532

1.70

5.39

1.1

—

(3023410) Appearance of Cerebral spinal fluid

109

678

1.61

5.36

1.9

1.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

152

1021

1.50

5.33

4.8

2.8

—

(3012565) Volume of 24 hour Urine

380

1.82

5.27

2.1

2.2

1975.08

1897.95

0.15

326

(3044927) Protein electrophoresis panel - Urine

126

816

1.55

5.24

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

268

1.98

5.23

2.6

2.9

28.83

28.38

umol/l

0.08

198

(4195642) Thrombophilia screening test

132

865

1.53

5.21

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

122

786

1.56

5.19

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

361

1.83

5.16

1.0

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

2.68

5.15

1.3

69.86

74.89

0.32

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

151

2.32

5.14

2.0

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

145

2.35

5.13

2.1

1.8

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

103

2.62

5.13

2.2

2.7

80.02

64.11

mg/l

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

685

5742

1.21

5.12

1.6

1.5

—

(3016879) Cocaine [Presence] in Urine

202

1444

1.41

5.12

3.8

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

175

1219

1.44

5.12

1.2

0.37

1.09

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

137

909

1.51

5.11

1.7

1.5

62.42

61.40

0.10

545

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

117

751

1.56

5.07

1.4

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

198

2.13

5.01

1.5

1.7

10.01

9.19

ug/l

0.44

198

(3012898) Urea [Moles/volume] in Urine

2.96

4.97

1.2

1.4

177.34

167.34

mmol/l

0.08

(3036071) Salmonella sp Ab [Titer] in Serum

173

2.20

4.94

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

201

1447

1.40

4.91

1.2

1.3

189.36

227.81

miu/ml

0.60

596

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

142

2.33

4.89

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

296

1.90

4.89

1.3

1.2

167.18

167.24

mmol/24h

0.00

296

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

283

1.91

4.84

2.1

2.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1295

11489

1.15

4.82

1.3

11.05

13.92

u/ml

0.75

489

4322

(3020682) Albumin/Creatinine [Ratio] in Urine

3057

28527

1.10

4.79

4.3

4.1

13.60

8.50

mg/mmol

2.83

1988

17739

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7058

72422

0.90

4.76

5.0

5.1

1.43

1.45

mmol/l

2.40

6403

66384

(3000060) B lymphocytes [#/volume] in Blood

163

2.21

4.76

1.8

2.5

1.10

1.02

e9/l

0.02

(3020911) Cortisol [Moles/time] in 24 hour Urine

197

2.08

4.68

1.4

1.5

112.94

251.40

nmol/24h

1.13

197

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

337

1.81

4.66

1.1

1.2

1.06

ratio

0.03

263

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

198

2.07

4.62

9.1

7.7

5.59

5.91

kpa

1.80

170

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

3.21

4.60

3.5

2.0

16.11

11.07

—

(3023511) Choriogonadotropin [Units/volume] in Urine

451

1.69

4.55

1.5

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

122

2.38

4.54

1.7

3.5

98.01

106.87

ng/l

—

(3023383) Lactate [Moles/volume] in Pleural fluid

284

1.87

4.47

1.3

3.54

3.19

mmol/l

0.29

259

(3046861) Legionella sp Ag [Presence] in Urine

3.27

4.45

1.3

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

155

2.20

4.44

2.2

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

279

1.87

4.38

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

279

1.87

4.38

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

210

1556

1.36

4.35

3.7

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.88

4.32

1.1

1.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

295

1.83

4.30

2.5

1.9

30.43

31.05

0.11

295

(3037692) Legionella sp identified in Specimen by Organism specific culture

281

1.85

4.29

1.6

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

622

1.56

4.29

2.4

16.43

29.98

iu/ml

0.93

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

232

1.94

4.27

1.1

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

263

2021

1.31

4.25

1.6

1.4

30.20

31.37

iu/l

0.22

228

1729

(3027008) Opiates [Presence] in Urine

210

1562

1.35

4.25

2.7

1.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

194

1427

1.37

4.22

1.2

44.80

48.76

u/ml

0.11

142

(3034891) Synovial lining cells/cells in Synovial fluid

379

1.72

4.18

1.6

1.4

1.33

3.38

1.65

(3010838) Calcium [Moles/time] in 24 hour Urine

177

1285

1.38

4.18

2.0

1.8

4.20

4.92

mmol/24h

2.33

153

1120

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

571

1.58

4.18

1.2

—

(3028300) Cannabinoids [Presence] in Urine

210

1569

1.35

4.14

3.7

1.8

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

10.00

4.00

1.0

264.14

245.84

u/ml

—

(40757373) Influenza virus identified in Isolate

149

2.15

4.00

1.8

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

201

1501

1.35

3.99

4.0

1.6

0.86

0.83

nmol/l

0.22

173

1282

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.02

3.95

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

132

920

1.44

3.95

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

170

2.06

3.94

9.3

7.6

5.75

5.45

kpa

0.26

170

(3027944) Amphetamines [Presence] in Urine

205

1540

1.34

3.92

3.7

1.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

219

1.92

3.89

1.4

1.2

3.15

3.73

umol/l

0.60

193

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

199

1491

1.34

3.88

1.2

1.3

37.93

33.35

u/l

0.15

171

1269

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

396

1.67

3.85

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

6.00

3.81

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

193

1.97

3.80

1.6

1.3

—

(3012516) Albumin [Mass/volume] in Urine

2969

27921

1.09

3.76

3.5

3.4

70.86

47.86

mg/l

2.66

2035

17908

(3039162) Centromere protein B Ab [Units/volume] in Serum

123

855

1.44

3.75

1.2

1.3

17.92

51.90

u/ml

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

348

1.70

3.68

1.3

1.2

46.00

58.98

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

440

1.62

3.68

1.5

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

109

2.30

3.67

1.2

1.3

88.08

190.22

ng/l

0.79

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7141

72968

0.91

3.63

5.1

5.2

4.36

4.54

mmol/l

38.80

6529

67316

(44786800) Granulocytes/Leukocytes in Body fluid

110

2.28

3.60

1.4

1.3

30.05

22.93

0.33

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

313

1.73

3.60

1.0

1.1

1639.09

1446.47

miu/ml

0.53

313

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

101

682

1.49

3.59

1.0

1.1

2.26

3.69

eliau/ml

0.93

297

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

126

888

1.42

3.59

2.2

2.0

23.18

27.57

mg/l

0.62

341

(3024471) HLA-A [Type]

184

1.96

3.56

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

7.78

3.55

1.6

2.1

222.00

234.67

ug/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

300

1.74

3.53

1.5

1.7

3.80

6.30

nmol/l

0.71

248

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

158

2.03

3.48

3.2

2.6

6.86

7.60

mmol/l

0.51

(3013139) Helicobacter pylori Ag [Presence] in Stool

512

4340

1.19

3.48

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

254

2002

1.28

3.46

2.1

2.0

—

(3024932) HLA-DR beta [Type]

180

1.95

3.41

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

205

1575

1.31

3.40

1.2

1.1

3.09

3.85

0.77

179

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

210

1.86

3.33

1.4

1.2

0.32

0.31

g/l

0.30

171

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

661

1.47

3.32

1.7

1.6

23.87

25.57

u/ml

0.14

134

(3014891) Appearance of Pleural fluid

156

1.99

3.23

1.6

1.4

—

(3020650) Glucose [Presence] in Urine

242

1.78

3.20

2.9

1.6

0.07

0.05

estimate

0.10

242

(40768443) Skin Pathology biopsy report

411

3446

1.20

3.18

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

586

1.49

3.17

3.3

2.7

35.59

30.21

mg/l

0.54

428

(3024263) Appearance of Synovial fluid

395

1.60

3.16

1.8

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.35

3.14

1.7

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

158

1.96

3.12

1.4

1.6

81.52

114.13

ug/l

1.24

139

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.67

3.08

2.0

1.5

0.24

2.85

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.67

3.08

2.0

1.5

0.54

1.94

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.67

3.08

2.0

1.5

0.26

2.56

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.67

3.08

2.0

1.5

0.52

0.86

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.67

3.08

2.0

1.5

2.19

3.44

mg/l

—

(3047189) Immunofixation for 24 hour Urine

398

1.59

3.08

1.7

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

235

1865

1.27

3.07

1.5

1.9

4.23

7.24

iu/l

0.39

709

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

344

1.63

3.06

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.33

3.01

1.0

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

113

2.13

2.99

1.1

1.2

0.75

0.68

umol/24h

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.55

2.98

2.0

1.5

0.92

1.74

mg/l

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

10.00

2.98

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

124

904

1.38

2.97

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

499

1.51

2.93

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

205

1.81

2.93

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

198

1.82

2.92

2.7

2.1

1.09

1.05

ug/l

0.05

192

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

142

1.97

2.88

2.0

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

109

782

1.40

2.88

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.39

2.86

10.7

9.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.59

2.86

1.7

1.8

48.93

47.21

umol/l

0.08

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

328

1.62

2.84

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

193

1.82

2.82

1.2

1.50

1.46

mmol/l

0.10

125

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

116

2.07

2.81

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3205

30519

1.07

2.80

5.4

5.6

3.00

3.61

ug/l

1.11

2836

27415

(3008116) Ketones [Moles/volume] in Urine by Test strip

180

1.84

2.76

2.0

1.3

0.21

0.30

mmol/l

—

(3036180) Methadone [Presence] in Urine

8.33

2.75

2.4

2.7

—

(3028433) Virus identified in Specimen by Culture

232

1.73

2.74

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

152

1.91

2.73

1.2

1.03

94.50

mg/l

1.25

110

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.20

2.72

2.8

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

174

1.84

2.71

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

248

1.70

2.70

1.9

1.5

—

(3033086) Enterovirus Ab [Titer] in Serum

6.00

2.69

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.24

2.69

1.4

1.2

42.00

115.68

ug/l

4.72

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

472

4070

1.17

2.69

2.1

1.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

256

2090

1.23

2.65

3.6

3.2

0.82

0.81

nmol/l

0.19

215

1707

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

227

1.72

2.65

1.3

1.2

10.30

14.88

pmol/l

0.53

(3045683) HLA typing for celiac disease panel - Blood or Tissue

281

1.64

2.62

1.1

1.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

514

1.46

2.58

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

410

1.51

2.54

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

430

3700

1.17

2.53

2.0

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

284

1.62

2.53

1.2

1.3

238.92

268.30

ug/l

0.07

159

(3051387) C reactive protein [Mass/volume] in Capillary blood

223

1806

1.24

2.51

5.2

3.3

29.52

30.42

mg/l

0.14

176

1275

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

501

1.46

2.50

1.9

124.47

106.10

ng/l

0.49

501

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.32

2.47

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

233

1.68

2.44

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.08

2.42

4.3

5.4

56.27

47.13

ug/min

0.20

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

145

1.86

2.40

2.1

1.6

2.60

2.21

ug/l

0.19

(3013166) Neutrophils/Leukocytes in Synovial fluid

234

1.67

2.40

1.2

1.4

56.52

60.79

0.29

194

(3036670) Protein [Mass/volume] in Synovial fluid

235

1.66

2.37

1.2

37.57

41.05

g/l

0.66

116

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.82

2.33

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

424

4875

0.86

2.31

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

202

1636

1.24

2.31

2.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

108

807

1.34

2.30

1.4

1.3

1.51

1.44

nmol/l

0.25

720

(3026051) Granulocytes/Leukocytes in Pleural fluid

207

1.69

2.29

1.3

17.71

21.92

0.42

172

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

110

825

1.34

2.28

1.1

2.41

3.24

0.38

118

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

495

1.44

2.28

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

495

1.44

2.28

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.07

2.26

1.1

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

673

1.37

2.25

1.5

1.4

0.24

0.29

nmol/l

0.80

484

(3020491) Glucose [Moles/volume] in Blood

523

1.42

2.21

1.9

2.1

7.68

7.21

mmol/l

0.51

367

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

482

1.43

2.20

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

474

1.44

2.19

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

114

1.93

2.19

2.1

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

210

1.67

2.18

1.5

1.6

3840.00

3254.12

titre

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.33

2.17

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

426

1.46

2.16

1.1

0.66

6.04

nmol/l

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

106

799

1.33

2.15

2.0

2.1

—

2.20

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.62

2.13

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

130

1.85

2.11

1.3

1.2

27.18

282.71

u/l

0.59

(3018333) Ribosomal P Ab [Presence] in Serum

462

1.43

2.10

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

623

1.37

2.08

1.0

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7326

74342

0.93

2.08

5.8

6.0

2.45

2.63

mmol/l

54.37

6673

68363

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6177

60448

1.06

2.06

49.8

20.8

329.96

332.00

g/l

53.27

6131

60052

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.50

2.05

1.4

1.1

32.00

31.36

mg/24h

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.02

2.05

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.40

2.02

1.0

5.58

17.26

u/l

1.38

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

680

1.34

1.98

1.0

1.1

—

62.35

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

596

1.36

1.95

1.3

124.00

477.50

titre

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

329

1.49

1.94

2.2

1.8

39.42

39.50

g/l

0.02

329

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.55

1.94

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.73

1.92

1.2

1.1

196.78

249.13

nmol/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.44

1.92

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.24

1.90

1.1

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

150

1.73

1.89

1.2

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.96

1.89

1.4

1.6

—

0.79

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

804

0.71

1.88

1.2

7.19

7.71

mmol/l

0.77

693

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

445

0.61

1.88

6.9

6.8

10.63

133.69

ug/l

1.08

286

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

136

1.77

1.86

1.1

1.2

322.53

296.41

pmol/l

0.14

103

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.86

1.86

8.9

3.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

341

1.47

1.85

1.2

1.7

1.91

5.65

ug/l

1.59

269

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.53

1.83

1.0

2.34

1.59

u/ml

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

4.17

1.82

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.06

1.80

1.2

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

719

1.31

1.78

1.0

1.1

—

15.11

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

394

1.42

1.78

2.2

2.7

226.07

204.07

u/l

0.91

389

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.33

1.74

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

217

1.57

1.72

1.2

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.85

1.71

1.0

2.00

2.85

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.85

1.71

2.4

1.2

0.94

2.27

mmol/24h

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.85

1.71

1.4

1.2

332.46

34.26

umol/24h

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1711

18038

0.94

1.70

3.1

3.3

0.78

0.82

ug/l

0.65

1198

12249

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

383

1.41

1.66

1.4

1.5

5.19

6.62

u/l

1.42

322

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

134

1.72

1.65

5.7

6.8

9.90

10.47

0.73

134

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

142

1.69

1.63

1.1

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.14

1.60

1.4

1.1

101.33

98.29

titre

0.05

(1002224) Polysomnography panel

241

2799

0.86

1.60

1.1

—

(3033099) Centromere Ab [Titer] in Serum

143

1.68

1.60

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

471

1.36

1.60

1.2

1.3

0.45

1.64

u/ml

2.17

286

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.50

1.59

1.1

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.50

1.59

17.6

11.0

100.63

109.22

g/l

—

(3000034) Microalbumin [Mass/volume] in Urine

741

1.28

1.59

2.6

3.0

38.76

56.22

mg/l

0.40

543

(3028679) Herpes simplex virus Ab [Presence] in Serum

314

1.43

1.53

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.59

1.51

3.4

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

152

1825

0.83

1.51

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

718

6609

1.09

1.51

2.6

2.2

12.62

13.08

nmol/l

0.77

637

5929

(3042010) Triglyceride [Moles/volume] in Pleural fluid

154

1.62

1.49

1.2

0.31

1.22

mmol/l

1.51

106

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

116

1.72

1.48

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

488

1.33

1.45

2.5

1.8

—

(40758292) HTLV I+II Ab panel - Serum

132

1.67

1.45

1.3

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

110

887

1.24

1.43

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

117

951

1.23

1.42

1.1

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

188

1.54

1.42

1.1

—

2.17

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

600

0.72

1.41

4.6

5.6

15.13

77.47

u/ml

—

199

(3019174) dRVVT (LA screen)

2.25

1.40

1.0

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.25

1.40

11.9

7.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.17

1.39

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

641

1.28

1.39

1.3

32.99

30.47

u/l

0.29

529

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.77

1.38

3.4

2.6

0.59

0.49

u/field

0.13

(3008898) HLA-B27 [Presence]

216

1864

1.16

1.37

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.80

1.36

1.1

1.0

—

(4034850) Laboratory test

271

2382

1.14

1.34

16.2

11.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

574

1.29

1.34

1.2

1.3

1.92

2.21

mmol/l

2.92

534

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

151

1.59

1.34

1.1

1133.33

866.67

titre

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.04

1.32

1.1

0.02

u/ml

0.06

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

129

1070

1.21

1.31

1.1

18.32

945.59

iu/ml

0.96

231

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

463

0.69

1.30

1.6

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.09

1.30

1.3

2.0

—

(3022475) Manganese [Moles/volume] in Blood

2.35

1.29

1.8

1.3

0.14

0.16

umol/l

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.78

1.28

1.0

1.1

—

mmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

182

2115

0.86

1.28

1.6

1.7

7.30

4.57

mg/l

0.45

139

1583

(40765096) Chromosome analysis panel by Banding

251

1.44

1.27

1.0

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

226

1972

1.15

1.26

2.1

2.3

169.81

111.47

ug/min

0.71

136

1156

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

340

0.65

1.25

1.5

76.05

60.30

ug/l

0.69

340

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

432

1.32

1.24

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

187

1.50

1.23

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

179

1.51

1.22

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

163

1.53

1.22

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

218

2485

0.87

1.19

1.9

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

559

1.27

1.18

2.1

4.78

3.60

ug/l

0.43

514

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.90

1.11

1.1

1.2

1.64

1.77

umol/24h

0.22

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

370

1.33

1.11

1.5

—

(3016750) Collection duration of Urine

467

1.29

1.10

2.0

2.1

476.75

497.22

min

0.55

321

(3025130) Human papilloma virus identified in Specimen

736

1.22

1.09

1.7

1.8

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.95

1.08

7.0

2.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

161

1390

1.16

1.08

1.5

—

(3025577) Chromium [Mass/volume] in Blood

549

1.26

1.07

2.2

2.1

2.39

2.35

ug/l

0.03

453

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.76

1.06

2.5

2.3

0.55

0.64

ug/l

0.52

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

457

4203

1.09

1.05

1.3

54.20

54.03

au/ml

0.00

299

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

195

1.44

1.03

10.2

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

532

0.75

1.03

1.1

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

445

4098

1.09

1.01

1.1

1.2

107.54

130.90

u/ml

0.76

136

1487

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.89

1.01

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

147

1.50

1.00

1.4

1.7

—

(4015189) Microbial culture of sputum

197

1.42

0.99

2.6

1.9

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.71

0.98

1.1

1.0

112.28

81.58

ug/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.17

0.98

1.0

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.67

0.97

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

241

1.37

0.96

1.1

99.80

94.75

0.50

179

(21491868) Cryoglobulin [Mass/volume] in Serum

268

1.34

0.93

1.1

—

0.28

g/l

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.22

0.93

1.2

1.1

0.03

0.46

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

975

0.83

0.93

1.6

972.10

1012.79

mu/l

0.14

789

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

237

2129

1.12

0.91

2.1

1.8

43.15

42.98

nmol/l

0.04

231

2061

(3025018) Bordetella pertussis Ab [Titer] in Serum

393

1.27

0.90

1.3

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

127

1.50

0.88

1.9

3.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

495

4613

1.08

0.87

2.4

38.66

22.68

au/ml

1.51

421

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

423

1.25

0.85

1.1

7.64

10.43

iu/ml

0.70

101

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.78

0.84

2.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

907

9513

0.95

0.83

4.8

5.1

33.73

32.89

1.30

618

6120

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.74

0.82

3.4

5.7

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.70

0.80

3.4

3.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

112

969

1.16

0.79

1.1

41.34

14.92

au/ml

1.19

207

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.72

0.79

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

419

0.76

0.79

1.4

1.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.79

0.0

1.0

—

8.23

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.67

0.78

1.1

—

(40768800) Prostate Pathology biopsy report

182

2027

0.90

0.77

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.76

0.76

1.0

1.7

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.76

0.0

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

392

3647

1.08

0.75

1.7

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.84

0.73

1.0

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

1.79

0.72

1.1

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

388

1.24

0.72

1.4

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.58

0.71

1.3

3.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

508

1.20

0.70

1.6

1.7

271.15

346.15

mu/l

1.62

409

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.71

0.69

1.0

—

(3004775) Volume in Urine collected for unspecified duration

665

1.17

0.69

2.0

2.2

690.88

654.04

0.29

425

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.51

0.69

1.3

1.6

—

(3013862) HLA-DP [Type]

1.85

0.68

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.59

0.68

1.3

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

110

1.45

0.68

1.0

1.1

24.08

18.16

u/l

—

(3006462) Nitrate [Presence] in Urine

329

1.25

0.67

2.6

3.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

188

1.33

0.66

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.59

0.65

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

645

0.84

0.64

1.6

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.52

0.62

1.1

1.4

—

692.70

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6865

69142

0.97

0.60

4.5

4.3

1.35

1.28

mmol/l

12.95

6196

62634

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.50

0.59

3.7

2.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.53

0.59

1.0

1.1

13.40

11.79

iu/ml

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

363

1.21

0.58

1.3

0.57

0.56

ratio

0.05

209

(3051101) Glucose [Moles/volume] in Cord blood

166

1.33

0.58

3.8

7.0

8.81

8.69

mmol/l

0.06

166

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.46

0.57

1.2

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7267

72159

1.03

0.55

5.6

5.3

6.09

6.04

mmol/l

2.47

6608

65413

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

274

0.77

0.55

1.1

—

(3001729) Color of Synovial fluid

1.54

0.55

1.1

1.6

—

(3017509) Phencyclidine [Presence] in Urine

1.58

0.54

1.3

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.58

0.54

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

142

1.34

0.54

1.1

0.31

1.40

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

108

1.39

0.53

1.1

15.46

35.49

iu/ml

1.86

108

(3025549) Creatine [Moles/time] in 24 hour Urine

1.51

0.52

1.5

1.4

—

(44813793) Dust mix specific IgE antibody measurement

405

1.19

0.52

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

533

0.84

0.52

1.7

1.4

1.32

1.19

ratio

0.31

318

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

533

0.84

0.52

1.7

1.4

0.96

0.94

ratio

0.11

318

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

533

0.84

0.52

1.7

1.4

1.05

1.14

ratio

0.34

318

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

326

0.80

0.51

1.3

1.2

6.31

6.09

mmol/l

0.38

306

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.50

0.51

1.0

1.1

—

4.77

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.41

0.51

2.6

4.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

233

1.24

0.50

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

233

1.24

0.50

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

233

1.24

0.50

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

233

1.24

0.50

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.46

0.50

6.0

4.6

—

0.00

estimate

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.49

0.49

1.5

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.52

0.48

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

528

0.85

0.47

1.6

1.4

—

(40768793) Breast Pathology biopsy report

178

1645

1.08

0.47

1.2

1.3

—

(4211845) Urine protein measurement

373

1.18

0.47

2.7

3.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.46

0.46

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.45

1.0

1.1

—

(4133840) Spirometry

165

1.27

0.44

1.3

1.1

—

(3034426) Prothrombin time (PT)

201

1.24

0.44

1.1

1.2

29.88

28.92

0.18

201

(3002523) Influenza virus A Ag [Presence] in Specimen

102

923

1.11

0.44

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

447

0.85

0.43

1.7

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

405

1.16

0.42

1.8

2.2

145.00

166.08

ug/min

0.09

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.38

0.42

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.40

0.42

1.6

1.4

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

183

0.76

0.40

1.4

1.5

8.20

8.65

mmol/l

0.34

174

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

101

0.69

0.39

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

101

0.69

0.39

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

101

0.69

0.39

1.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

101

922

1.10

0.38

1.1

—

(3005033) Fetal Nuchal fold Thickness US

441

0.86

0.38

1.7

1.4

1.30

1.26

0.24

305

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

247

0.81

0.38

1.5

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.34

0.38

2.3

2.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.29

0.36

1.0

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.33

0.35

1.7

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

441

1.13

0.35

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

162

1.23

0.35

1.0

1.2

—

340.00

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.34

0.34

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.30

0.33

1.7

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

219

1.19

0.32

5.7

5.1

68.88

70.28

0.12

176

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

101

1.29

0.31

1.4

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7066

70931

0.98

0.30

7.3

6.7

40.10

39.96

mmol/mol

0.67

6522

65548

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

315

1.14

0.30

3.3

2.4

60.31

54.60

umol/l

0.36

271

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.29

0.29

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

260

1.15

0.28

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

197

1.17

0.25

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

571

0.91

0.25

1.6

1.5

48.41

61.16

ug/l

1.89

465

(3043238) Trisomy 21 risk [Likelihood] in Fetus

456

0.90

0.25

1.7

1.5

—

(44806071) Cardiolipin IgM antibody measurement

1.18

0.24

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.72

0.24

8.0

5.9

16.50

7.99

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.72

0.24

4.0

2.9

26.33

43.98

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.27

0.22

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

670

1.07

0.22

1.0

1.1

3.28

3.66

u/ml

0.08

301

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

314

1.11

0.22

1.3

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

111

1049

1.06

0.22

1.1

0.73

1.92

u/ml

2.93

569

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

210

1.14

0.21

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

107

1.21

0.21

1.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

166.50

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

296

1.11

0.21

1.1

27.00

524.68

ng/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

5.8

—

0.29

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.24

0.20

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

721

1.07

0.20

1.0

1.1

1.92

3.39

u/ml

0.77

368

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

354

1.10

0.20

1.2

1.1

31.18

18.40

u/ml

0.45

141

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

202

1.14

0.20

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

122

0.82

0.19

1.0

—

(3022689) Creatine [Moles/volume] in Urine

270

1.11

0.18

1.8

1.4

7.10

8.24

mmol/l

0.76

270

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

176

1695

1.04

0.18

2.4

1.8

197.92

204.10

pmol/l

0.43

171

1589

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.15

0.17

1.4

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

176

1.14

0.17

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.15

0.15

1.0

1.1

—

(4212803) Bone marrow aspirate examination

1.14

0.15

1.1

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

129

0.85

0.14

1.4

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.08

0.14

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

193

1987

0.97

0.14

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

295

1.08

0.13

1.0

1.1

0.94

1.29

u/ml

0.30

102

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

211

0.90

0.13

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

1.10

0.12

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

191

1.10

0.11

1.0

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

817

1.04

0.11

1.1

1.40

1.30

u/ml

0.03

417

(3015076) Soybean IgE Ab [Units/volume] in Serum

250

1.08

0.11

1.0

0.21

1.55

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

889

1.03

0.10

1.1

0.96

3.51

u/ml

5.48

448

(44806420) Estimation of glomerular filtration rate

732

1.04

0.09

2.7

2.6

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

234

1.07

0.08

1.0

1.1

13.08

11.32

mm/h

0.33

234

(40762814) Titanium [Mass/volume] in Blood

157

1.08

0.07

2.6

2.3

3.26

4.15

ug/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

622

1.03

0.05

1.0

0.04

0.30

u/ml

2.21

217

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

584

1.03

0.05

1.1

1.0

32.61

43.88

ng/l

2.16

403

(4146454) Self-monitoring of blood glucose

902

1.02

0.04

2.4

2.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

585

1.03

0.04

1.1

1.0

258.31

331.16

ng/l

2.62

411

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

477

1.03

0.04

1.1

278.85

304.37

mg/l

0.51

414

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

378

1.03

0.04

5.2

5.4

27.29

220.91

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

349

1.03

0.03

1.1

1.07

1.15

u/l

0.27

158

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2457

24516

1.00

0.03

4.5

4.6

21.65

22.39

1.57

1236

12764

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

828

8301

1.00

0.02

1.5

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

261

1.03

0.02

1.1

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

281

1.03

0.02

1.0

1.1

0.62

1.68

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

473

1.01

0.01

1.3

165.55

186.54

pmol/l

0.38

473

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

584

1.01

0.00

1.1

1.0

662.41

698.33

ng/l

0.27

392

(40765089) Chromosome analysis panel - Blood by G-banded

1.05

0.00

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

156

1.03

0.00

1.0

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

198

1.01

0.00

1.7

1.2

31.00

35.41

0.22

129

(3008401) Mugwort IgE Ab [Units/volume] in Serum

865

1.01

0.00

1.1

0.52

0.99

u/ml

0.68

384

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

102

0.98

0.00

1.0

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

501

1.00

0.00

1.1

38.31

45.41

mg/l

0.82

413

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

6.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

31.20

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.4

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.4

—

0.76

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.50

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.00

-0.00

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

0.79

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.88

-0.00

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

1600.00

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.96

-0.00

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.02

-0.00

1.0

1.1

—

2.57

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHILEUS and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_OTHILEUS	2.598 [2.35, 2.87]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.489

During the follow-up period (1.1.1998 — 31.12.2019), 12605 out of 24341 females with K11_OTHILEUS died.

Males

Parameter	HR [95% CI]	p-value
K11_OTHILEUS	2.576 [2.31, 2.87]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 11756 out of 23689 males with K11_OTHILEUS died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHILEUS.

N-year risk	Females	Males
1	0.238%	0.443%
5	1.486%	2.437%
10	4.369%	6.074%
15	7.892%	12.221%
20	13.355%	20.602%

Relationships between endpoints

↥

Index endpoint: K11_OTHILEUS – Other or unspecified ileus, impaction or obstruction

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other or unspecified ileus, impaction or obstruction

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints